###begin article-title 0
ARSACS in the Dutch population: a frequent cause of early-onset cerebellar ataxia
###end article-title 0
###begin p 1
###xml 532 533 532 533 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 543 544 543 544 <bold xmlns:xlink="http://www.w3.org/1999/xlink">S</bold>
###xml 651 655 651 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 808 812 808 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 1426 1430 1426 1430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 570 578 <span type="species:ncbi:9606">patients</span>
###xml 692 700 <span type="species:ncbi:9606">patients</span>
###xml 757 765 <span type="species:ncbi:9606">patients</span>
###xml 776 784 <span type="species:ncbi:9606">patients</span>
###xml 947 955 <span type="species:ncbi:9606">patients</span>
###xml 1302 1310 <span type="species:ncbi:9606">patients</span>
###xml 1569 1577 <span type="species:ncbi:9606">patients</span>
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS: MIM 270550) is a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. This disorder, considered to be rare, was first described in the late seventies among French Canadians in the isolated Charlevoix-Saguenay region of Quebec. Nowadays, it is known that the disorder is not only limited to this region but occurs worldwide. Our objective was to identify cases of autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) in Dutch patients with recessive early-onset cerebellar ataxia by sequencing the complete SACS gene. In a Dutch cohort of 43 index patients with ataxia onset before age 25, we identified 16 index patients (total 23 patients) with mutations in the SACS gene. Nine of them had homozygous mutations, and seven of them had compound heterozygous mutations. Retrospectively, the phenotype of patients carrying mutations was remarkably uniform: cerebellar ataxia with onset before age 13 years, lower limb spasticity and sensorimotor axonal neuropathy, and cerebellar (vermis) atrophy on magnetic resonance imaging, consistent with the core ARSACS phenotype previously described. The high rate of mutations (37%) identified in this cohort of Dutch patients suggests that ARSACS is substantially more frequent than previously estimated. We predict that the availability of SACS mutation analysis as well as an increasing awareness of the characteristic ARSACS phenotype will lead to the diagnosis of many additional patients, possibly even at a younger age.
###end p 1
###begin title 2
Keywords
###end title 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 452 453 452 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 762 763 762 763 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 1003 1004 1003 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 1065 1066 1065 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 1383 1384 1383 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 1385 1387 1385 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 1394 1398 1394 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 1476 1477 1476 1477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 1752 1753 1752 1753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 1807 1811 1807 1811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 2122 2123 2122 2123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 2251 2255 2251 2255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 1119 1127 <span type="species:ncbi:9606">patients</span>
###xml 1281 1289 <span type="species:ncbi:9606">patients</span>
###xml 1318 1324 <span type="species:ncbi:9103">Turkey</span>
###xml 2303 2311 <span type="species:ncbi:9606">patients</span>
Autosomal recessive spinocerebellar ataxias constitute a heterogeneous group of neurodegenerative disorders characterized by ataxia mostly due to progressive degeneration of the cerebellum, spinal cord tracts, and associated structures. The clinical phenotype of these disorders is broad and quite variable. A number of recent reviews presented clinical diagnostic strategies to differentiate between the various types of recessive cerebellar ataxias [1-3]. Van de Warrenburg et al. grouped them into recognizable and more or less specific phenotypes: (a) ataxia with neuro(no)pathy, (b) spastic ataxia, (c) ataxia with oculomotor apraxia, and (d) Ramsay Hunt syndrome. The most common form, and representative of the first group, is Friedreich's ataxia (FRDA). Autosomal recessive spastic ataxia of Charlevoix-Saguenay (MIM 270550), ARSACS, is a distinct form of hereditary early-onset spastic ataxia. The disease was first described in the Charlevoix-Saguenay region of Northeastern Quebec in Canada [4]. Two founder mutations were identified in this population [5]. Shortly after mutation analysis became available, patients outside Quebec were molecularly characterized. To date, apart from the two Quebec mutations, 27 different additional mutations have been found in ARSACS patients outside Quebec, namely from Turkey, Tunisia, Italy, Spain, Japan, and recently from Belgium [6-20]. The SACS gene is located on chromosome 13q12.12 and encodes the large protein sacsin [5]. Different transcripts of the gene have been identified, and in total, 11 different exons within the gene have been described. The large transcript NM_014363.4 reported recently () comprises nine coding exons consisting of 13,737 base pairs which encode 4,579 amino acids [6]. The large size of the total coding sequence of the SACS gene has precluded sequencing efforts for routine diagnostic use. The function of the sacsin protein is not yet known, but the protein may be involved in chaperone-mediated protein folding, as it contains a DnaJ domain and has some sequence similarity with the N terminus of the heat shock protein 90 (Hsp90) [5]. As ARSACS is now known to occur worldwide, we initiated a systematic mutation analysis by direct automated sequencing of the SACS exons and flanking intronic sequences in Dutch patients with an early-onset cerebellar ataxia presenting before the age of 25, with the aim of identifying additional mutations and determining the relative frequency of ARSACS among the autosomal recessive cerebellar ataxias in the Dutch population.
###end p 4
###begin title 5
Materials and methods
###end title 5
###begin title 6
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient selection
###end title 6
###begin p 7
###xml 535 536 535 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 632 633 632 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
###xml 114 122 <span type="species:ncbi:9606">patients</span>
###xml 419 427 <span type="species:ncbi:9606">patients</span>
###xml 454 462 <span type="species:ncbi:9606">Patients</span>
###xml 519 526 <span type="species:ncbi:9606">patient</span>
###xml 668 676 <span type="species:ncbi:9606">patients</span>
###xml 682 689 <span type="species:ncbi:9606">patient</span>
To determine the frequency of ARSACS among patients with early-onset cerebellar ataxia, we included in this study patients who presented with an early-onset cerebellar ataxia before the age of 25 and for whom Friedreich's ataxia was excluded through DNA mutation analysis. According to the clinical information which was either given on the DNA mutation analysis request form or gathered from medical records, 43 index patients fulfilled this criterion. Patients were recruited either through our own neurogenetics out-patient clinic (n = 26) as well as through referring neurologists and clinical geneticists from other hospitals (n = 17). Forty-one are native Dutch patients, one patient is of English descent, and one is of Turkish descent.
###end p 7
###begin title 8
Molecular analysis
###end title 8
###begin p 9
###xml 187 191 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 395 399 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 1129 1133 1129 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 1236 1240 1236 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 1349 1353 1349 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 45 53 <span type="species:ncbi:9606">patients</span>
###xml 1054 1062 <span type="species:ncbi:9606">patients</span>
###xml 1257 1265 <span type="species:ncbi:9606">patients</span>
Molecular analysis was performed in 43 index patients. Genomic DNA was extracted from blood lymphocytes using standard procedures. We performed sequence analysis of the transcript of the SACS gene (NM_014363.4) mentioned in the NCBI database () that comprises nine exons. The nine coding exons, including the gigantic exon described previously [5], as well as flanking intronic sequences of the SACS gene [GenBank reference sequence accession number NM_014363.4 (NCBI)] were polymerase chain reaction (PCR)-amplified from genomic DNA by using 45 primer pairs. The A of the ATG start codon in exon 1 is defined as "position 1" for the numbering of nucleotides in mutation and DNA-variant nomenclature. Primer sequences and amplification parameters are available on request. Purified PCR products (using Multiscreen  filter plate, Millipore Carrigtwohill, Cork, Ireland) were directly sequenced on an ABI 3730 automated sequencer (Applied Biosystems, Foster City, CA, USA). In addition, mutation analysis was performed in affected siblings or relatives of patients with one homozygous or two compound heterozygous mutations in the SACS gene. If available, parental DNA was analyzed to confirm the location of the mutation(s) in different SACS alleles. In all patients in whom no mutations in the nine coding exons of the NM_014363.4 transcript of the SACS gene could be identified, we performed molecular analysis of the additional two exons within the other transcripts.
###end p 9
###begin title 10
Clinical assessment
###end title 10
###begin p 11
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 247 248 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 1504 1506 1504 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 1715 1717 1715 1717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 1846 1853 1846 1853 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 1902 1906 1902 1906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 1853 1911 1853 1911 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="12">Homozygous or compound heterozygous mutations in <italic>SACS</italic> gene</p>
###xml 1853 1911 1853 1911 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="12">Homozygous or compound heterozygous mutations in <italic>SACS</italic> gene</p></caption>
###xml 1911 1917 1911 1917 <th xmlns:xlink="http://www.w3.org/1999/xlink">Family</th>
###xml 1917 1930 1917 1930 <th xmlns:xlink="http://www.w3.org/1999/xlink">Consanguinity</th>
###xml 1930 1939 1930 1939 <th xmlns:xlink="http://www.w3.org/1999/xlink">Mutations</th>
###xml 1939 1955 1939 1955 <th xmlns:xlink="http://www.w3.org/1999/xlink">Type of mutation</th>
###xml 1911 1955 1911 1955 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>Family</th><th>Consanguinity</th><th>Mutations</th><th>Type of mutation</th></tr>
###xml 1911 1955 1911 1955 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th>Family</th><th>Consanguinity</th><th>Mutations</th><th>Type of mutation</th></tr></thead>
###xml 1955 1956 1955 1956 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1</td>
###xml 1956 1959 1956 1959 <td xmlns:xlink="http://www.w3.org/1999/xlink">Yes</td>
###xml 1959 1980 1959 1980 <td xmlns:xlink="http://www.w3.org/1999/xlink">p.Gln4054X/p.Gln4054X</td>
###xml 1980 1988 1980 1988 <td xmlns:xlink="http://www.w3.org/1999/xlink">Nonsense</td>
###xml 1955 1988 1955 1988 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">1</td><td>Yes</td><td>p.Gln4054X/p.Gln4054X</td><td>Nonsense</td></tr>
###xml 1988 1989 1988 1989 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2</td>
###xml 1989 1992 1989 1992 <td xmlns:xlink="http://www.w3.org/1999/xlink">Yes</td>
###xml 1992 2011 1992 2011 <td xmlns:xlink="http://www.w3.org/1999/xlink">p.Arg728X/p.Arg728X</td>
###xml 2011 2019 2011 2019 <td xmlns:xlink="http://www.w3.org/1999/xlink">Nonsense</td>
###xml 1988 2019 1988 2019 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">2</td><td>Yes</td><td>p.Arg728X/p.Arg728X</td><td>Nonsense</td></tr>
###xml 2019 2020 2019 2020 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3</td>
###xml 2020 2022 2020 2022 <td xmlns:xlink="http://www.w3.org/1999/xlink">No</td>
###xml 2022 2045 2022 2045 <td xmlns:xlink="http://www.w3.org/1999/xlink">p.Lys1715X/p.Arg4331Gln</td>
###xml 2045 2062 2045 2062 <td xmlns:xlink="http://www.w3.org/1999/xlink">Nonsense/Missense</td>
###xml 2019 2062 2019 2062 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">3</td><td>No</td><td>p.Lys1715X/p.Arg4331Gln</td><td>Nonsense/Missense</td></tr>
###xml 2062 2063 2062 2063 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4</td>
###xml 2063 2065 2063 2065 <td xmlns:xlink="http://www.w3.org/1999/xlink">No</td>
###xml 2065 2087 2065 2087 <td xmlns:xlink="http://www.w3.org/1999/xlink">p.Gln4054X/p.Arg2002fs</td>
###xml 2087 2106 2087 2106 <td xmlns:xlink="http://www.w3.org/1999/xlink">Nonsense/Frameshift</td>
###xml 2062 2106 2062 2106 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">4</td><td>No</td><td>p.Gln4054X/p.Arg2002fs</td><td>Nonsense/Frameshift</td></tr>
###xml 2107 2108 2107 2108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2106 2108 2106 2108 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5<sup>a</sup></td>
###xml 2108 2111 2108 2111 <td xmlns:xlink="http://www.w3.org/1999/xlink">Yes</td>
###xml 2111 2132 2111 2132 <td xmlns:xlink="http://www.w3.org/1999/xlink">p.Glu1653X/p.Glu1653X</td>
###xml 2132 2140 2132 2140 <td xmlns:xlink="http://www.w3.org/1999/xlink">Nonsense</td>
###xml 2106 2140 2106 2140 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">5<sup>a</sup></td><td>Yes</td><td>p.Glu1653X/p.Glu1653X</td><td>Nonsense</td></tr>
###xml 2140 2141 2140 2141 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6</td>
###xml 2141 2143 2141 2143 <td xmlns:xlink="http://www.w3.org/1999/xlink">No</td>
###xml 2143 2166 2143 2166 <td xmlns:xlink="http://www.w3.org/1999/xlink">p.Gln4054X/c.2094-2 A&gt;G</td>
###xml 2166 2186 2166 2186 <td xmlns:xlink="http://www.w3.org/1999/xlink">Nonsense/Splice-site</td>
###xml 2140 2186 2140 2186 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">6</td><td>No</td><td>p.Gln4054X/c.2094-2 A&gt;G</td><td>Nonsense/Splice-site</td></tr>
###xml 2186 2187 2186 2187 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7</td>
###xml 2187 2190 2187 2190 <td xmlns:xlink="http://www.w3.org/1999/xlink">Yes</td>
###xml 2190 2213 2190 2213 <td xmlns:xlink="http://www.w3.org/1999/xlink">p.Asp168Tyr/p.Asp168Tyr</td>
###xml 2213 2221 2213 2221 <td xmlns:xlink="http://www.w3.org/1999/xlink">Missense</td>
###xml 2186 2221 2186 2221 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">7</td><td>Yes</td><td>p.Asp168Tyr/p.Asp168Tyr</td><td>Missense</td></tr>
###xml 2221 2222 2221 2222 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8</td>
###xml 2222 2224 2222 2224 <td xmlns:xlink="http://www.w3.org/1999/xlink">No</td>
###xml 2224 2245 2224 2245 <td xmlns:xlink="http://www.w3.org/1999/xlink">p.Gln4054X/p.Gln4054X</td>
###xml 2245 2253 2245 2253 <td xmlns:xlink="http://www.w3.org/1999/xlink">Nonsense</td>
###xml 2221 2253 2221 2253 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">8</td><td>No</td><td>p.Gln4054X/p.Gln4054X</td><td>Nonsense</td></tr>
###xml 2253 2254 2253 2254 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">9</td>
###xml 2254 2257 2254 2257 <td xmlns:xlink="http://www.w3.org/1999/xlink">Yes</td>
###xml 2257 2282 2257 2282 <td xmlns:xlink="http://www.w3.org/1999/xlink">p.2801delGln/p.2801delGln</td>
###xml 2282 2299 2282 2299 <td xmlns:xlink="http://www.w3.org/1999/xlink">In frame deletion</td>
###xml 2253 2299 2253 2299 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">9</td><td>Yes</td><td>p.2801delGln/p.2801delGln</td><td>In frame deletion</td></tr>
###xml 2299 2301 2299 2301 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">10</td>
###xml 2301 2310 2301 2310 <td xmlns:xlink="http://www.w3.org/1999/xlink">Not known</td>
###xml 2310 2331 2310 2331 <td xmlns:xlink="http://www.w3.org/1999/xlink">p.Gln4054X/p.Gln4054X</td>
###xml 2331 2339 2331 2339 <td xmlns:xlink="http://www.w3.org/1999/xlink">Nonsense</td>
###xml 2299 2339 2299 2339 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">10</td><td>Not known</td><td>p.Gln4054X/p.Gln4054X</td><td>Nonsense</td></tr>
###xml 2339 2341 2339 2341 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11</td>
###xml 2341 2343 2341 2343 <td xmlns:xlink="http://www.w3.org/1999/xlink">No</td>
###xml 2343 2372 2343 2372 <td xmlns:xlink="http://www.w3.org/1999/xlink">c.1891+1 del G/c.1891+1 del G</td>
###xml 2372 2383 2372 2383 <td xmlns:xlink="http://www.w3.org/1999/xlink">Splice-site</td>
###xml 2339 2383 2339 2383 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">11</td><td>No</td><td>c.1891+1 del G/c.1891+1 del G</td><td>Splice-site</td></tr>
###xml 2383 2385 2383 2385 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">12</td>
###xml 2385 2394 2385 2394 <td xmlns:xlink="http://www.w3.org/1999/xlink">Not known</td>
###xml 2394 2415 2394 2415 <td xmlns:xlink="http://www.w3.org/1999/xlink">p.Gln1709X/p.Gln4054X</td>
###xml 2415 2423 2415 2423 <td xmlns:xlink="http://www.w3.org/1999/xlink">Nonsense</td>
###xml 2383 2423 2383 2423 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">12</td><td>Not known</td><td>p.Gln1709X/p.Gln4054X</td><td>Nonsense</td></tr>
###xml 2423 2425 2423 2425 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">13</td>
###xml 2425 2427 2425 2427 <td xmlns:xlink="http://www.w3.org/1999/xlink">No</td>
###xml 2427 2449 2427 2449 <td xmlns:xlink="http://www.w3.org/1999/xlink">p. Arg321X/p. Arg3636X</td>
###xml 2449 2457 2449 2457 <td xmlns:xlink="http://www.w3.org/1999/xlink">Nonsense</td>
###xml 2423 2457 2423 2457 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">13</td><td>No</td><td>p. Arg321X/p. Arg3636X</td><td>Nonsense</td></tr>
###xml 2457 2459 2457 2459 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">14</td>
###xml 2459 2461 2459 2461 <td xmlns:xlink="http://www.w3.org/1999/xlink">No</td>
###xml 2461 2482 2461 2482 <td xmlns:xlink="http://www.w3.org/1999/xlink">p.Gln4054X/p.Gln4054X</td>
###xml 2482 2490 2482 2490 <td xmlns:xlink="http://www.w3.org/1999/xlink">Nonsense</td>
###xml 2457 2490 2457 2490 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">14</td><td>No</td><td>p.Gln4054X/p.Gln4054X</td><td>Nonsense</td></tr>
###xml 2490 2492 2490 2492 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">15</td>
###xml 2492 2494 2492 2494 <td xmlns:xlink="http://www.w3.org/1999/xlink">No</td>
###xml 2494 2513 2494 2513 <td xmlns:xlink="http://www.w3.org/1999/xlink">p.Arg321X/p.Trp492X</td>
###xml 2513 2530 2513 2530 <td xmlns:xlink="http://www.w3.org/1999/xlink">Nonsense/Nonsense</td>
###xml 2490 2530 2490 2530 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">15</td><td>No</td><td>p.Arg321X/p.Trp492X</td><td>Nonsense/Nonsense</td></tr>
###xml 2532 2533 2532 2533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2530 2533 2530 2533 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">16<sup>a</sup></td>
###xml 2533 2535 2533 2535 <td xmlns:xlink="http://www.w3.org/1999/xlink">No</td>
###xml 2535 2559 2535 2559 <td xmlns:xlink="http://www.w3.org/1999/xlink">p.Leu3304fs/p.Leu3481Pro</td>
###xml 2559 2578 2559 2578 <td xmlns:xlink="http://www.w3.org/1999/xlink">Frameshift/Missense</td>
###xml 2530 2578 2530 2578 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char">16<sup>a</sup></td><td>No</td><td>p.Leu3304fs/p.Leu3481Pro</td><td>Frameshift/Missense</td></tr>
###xml 1955 2578 1955 2578 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td char="." align="char">1</td><td>Yes</td><td>p.Gln4054X/p.Gln4054X</td><td>Nonsense</td></tr><tr><td char="." align="char">2</td><td>Yes</td><td>p.Arg728X/p.Arg728X</td><td>Nonsense</td></tr><tr><td char="." align="char">3</td><td>No</td><td>p.Lys1715X/p.Arg4331Gln</td><td>Nonsense/Missense</td></tr><tr><td char="." align="char">4</td><td>No</td><td>p.Gln4054X/p.Arg2002fs</td><td>Nonsense/Frameshift</td></tr><tr><td char="." align="char">5<sup>a</sup></td><td>Yes</td><td>p.Glu1653X/p.Glu1653X</td><td>Nonsense</td></tr><tr><td char="." align="char">6</td><td>No</td><td>p.Gln4054X/c.2094-2 A&gt;G</td><td>Nonsense/Splice-site</td></tr><tr><td char="." align="char">7</td><td>Yes</td><td>p.Asp168Tyr/p.Asp168Tyr</td><td>Missense</td></tr><tr><td char="." align="char">8</td><td>No</td><td>p.Gln4054X/p.Gln4054X</td><td>Nonsense</td></tr><tr><td char="." align="char">9</td><td>Yes</td><td>p.2801delGln/p.2801delGln</td><td>In frame deletion</td></tr><tr><td char="." align="char">10</td><td>Not known</td><td>p.Gln4054X/p.Gln4054X</td><td>Nonsense</td></tr><tr><td char="." align="char">11</td><td>No</td><td>c.1891+1 del G/c.1891+1 del G</td><td>Splice-site</td></tr><tr><td char="." align="char">12</td><td>Not known</td><td>p.Gln1709X/p.Gln4054X</td><td>Nonsense</td></tr><tr><td char="." align="char">13</td><td>No</td><td>p. Arg321X/p. Arg3636X</td><td>Nonsense</td></tr><tr><td char="." align="char">14</td><td>No</td><td>p.Gln4054X/p.Gln4054X</td><td>Nonsense</td></tr><tr><td char="." align="char">15</td><td>No</td><td>p.Arg321X/p.Trp492X</td><td>Nonsense/Nonsense</td></tr><tr><td char="." align="char">16<sup>a</sup></td><td>No</td><td>p.Leu3304fs/p.Leu3481Pro</td><td>Frameshift/Missense</td></tr></tbody>
###xml 1911 2578 1911 2578 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th>Family</th><th>Consanguinity</th><th>Mutations</th><th>Type of mutation</th></tr></thead><tbody><tr><td char="." align="char">1</td><td>Yes</td><td>p.Gln4054X/p.Gln4054X</td><td>Nonsense</td></tr><tr><td char="." align="char">2</td><td>Yes</td><td>p.Arg728X/p.Arg728X</td><td>Nonsense</td></tr><tr><td char="." align="char">3</td><td>No</td><td>p.Lys1715X/p.Arg4331Gln</td><td>Nonsense/Missense</td></tr><tr><td char="." align="char">4</td><td>No</td><td>p.Gln4054X/p.Arg2002fs</td><td>Nonsense/Frameshift</td></tr><tr><td char="." align="char">5<sup>a</sup></td><td>Yes</td><td>p.Glu1653X/p.Glu1653X</td><td>Nonsense</td></tr><tr><td char="." align="char">6</td><td>No</td><td>p.Gln4054X/c.2094-2 A&gt;G</td><td>Nonsense/Splice-site</td></tr><tr><td char="." align="char">7</td><td>Yes</td><td>p.Asp168Tyr/p.Asp168Tyr</td><td>Missense</td></tr><tr><td char="." align="char">8</td><td>No</td><td>p.Gln4054X/p.Gln4054X</td><td>Nonsense</td></tr><tr><td char="." align="char">9</td><td>Yes</td><td>p.2801delGln/p.2801delGln</td><td>In frame deletion</td></tr><tr><td char="." align="char">10</td><td>Not known</td><td>p.Gln4054X/p.Gln4054X</td><td>Nonsense</td></tr><tr><td char="." align="char">11</td><td>No</td><td>c.1891+1 del G/c.1891+1 del G</td><td>Splice-site</td></tr><tr><td char="." align="char">12</td><td>Not known</td><td>p.Gln1709X/p.Gln4054X</td><td>Nonsense</td></tr><tr><td char="." align="char">13</td><td>No</td><td>p. Arg321X/p. Arg3636X</td><td>Nonsense</td></tr><tr><td char="." align="char">14</td><td>No</td><td>p.Gln4054X/p.Gln4054X</td><td>Nonsense</td></tr><tr><td char="." align="char">15</td><td>No</td><td>p.Arg321X/p.Trp492X</td><td>Nonsense/Nonsense</td></tr><tr><td char="." align="char">16<sup>a</sup></td><td>No</td><td>p.Leu3304fs/p.Leu3481Pro</td><td>Frameshift/Missense</td></tr></tbody></table>
###xml 2578 2579 2578 2579 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2578 2597 2578 2597 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="13"><sup>a</sup>Non-Dutch patients</p>
###xml 2578 2597 2578 2597 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="13"><sup>a</sup>Non-Dutch patients</p></table-wrap-foot>
###xml 1846 2597 1846 2597 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="12">Homozygous or compound heterozygous mutations in <italic>SACS</italic> gene</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Family</th><th>Consanguinity</th><th>Mutations</th><th>Type of mutation</th></tr></thead><tbody><tr><td char="." align="char">1</td><td>Yes</td><td>p.Gln4054X/p.Gln4054X</td><td>Nonsense</td></tr><tr><td char="." align="char">2</td><td>Yes</td><td>p.Arg728X/p.Arg728X</td><td>Nonsense</td></tr><tr><td char="." align="char">3</td><td>No</td><td>p.Lys1715X/p.Arg4331Gln</td><td>Nonsense/Missense</td></tr><tr><td char="." align="char">4</td><td>No</td><td>p.Gln4054X/p.Arg2002fs</td><td>Nonsense/Frameshift</td></tr><tr><td char="." align="char">5<sup>a</sup></td><td>Yes</td><td>p.Glu1653X/p.Glu1653X</td><td>Nonsense</td></tr><tr><td char="." align="char">6</td><td>No</td><td>p.Gln4054X/c.2094-2 A&gt;G</td><td>Nonsense/Splice-site</td></tr><tr><td char="." align="char">7</td><td>Yes</td><td>p.Asp168Tyr/p.Asp168Tyr</td><td>Missense</td></tr><tr><td char="." align="char">8</td><td>No</td><td>p.Gln4054X/p.Gln4054X</td><td>Nonsense</td></tr><tr><td char="." align="char">9</td><td>Yes</td><td>p.2801delGln/p.2801delGln</td><td>In frame deletion</td></tr><tr><td char="." align="char">10</td><td>Not known</td><td>p.Gln4054X/p.Gln4054X</td><td>Nonsense</td></tr><tr><td char="." align="char">11</td><td>No</td><td>c.1891+1 del G/c.1891+1 del G</td><td>Splice-site</td></tr><tr><td char="." align="char">12</td><td>Not known</td><td>p.Gln1709X/p.Gln4054X</td><td>Nonsense</td></tr><tr><td char="." align="char">13</td><td>No</td><td>p. Arg321X/p. Arg3636X</td><td>Nonsense</td></tr><tr><td char="." align="char">14</td><td>No</td><td>p.Gln4054X/p.Gln4054X</td><td>Nonsense</td></tr><tr><td char="." align="char">15</td><td>No</td><td>p.Arg321X/p.Trp492X</td><td>Nonsense/Nonsense</td></tr><tr><td char="." align="char">16<sup>a</sup></td><td>No</td><td>p.Leu3304fs/p.Leu3481Pro</td><td>Frameshift/Missense</td></tr></tbody></table><table-wrap-foot><p textid="13"><sup>a</sup>Non-Dutch patients</p></table-wrap-foot></table-wrap>
###xml 2597 2604 2597 2604 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 2604 2654 2604 2654 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="14">Phenotypic characteristics of patients with ARSACS</p>
###xml 2604 2654 2604 2654 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="14">Phenotypic characteristics of patients with ARSACS</p></caption>
###xml 2654 2660 2654 2660 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Family</th>
###xml 2660 2673 2660 2673 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Patient (M/F)</th>
###xml 2673 2693 2673 2693 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Age at onset (years)</th>
###xml 2693 2717 2693 2717 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Disease duration (years)</th>
###xml 2730 2732 2730 2732 <sup xmlns:xlink="http://www.w3.org/1999/xlink">31</sup>
###xml 2717 2732 2717 2732 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Disease stage<sup>31</sup></th>
###xml 2732 2747 2732 2747 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Gait spasticity</th>
###xml 2747 2774 2747 2774 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Lower body ataxia score (%)</th>
###xml 2774 2795 2774 2795 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Lower limb spasticity</th>
###xml 2795 2822 2795 2822 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Upper body ataxia score (%)</th>
###xml 2822 2843 2822 2843 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Upper limb spasticity</th>
###xml 2843 2869 2843 2869 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Remaining ataxia score (%)</th>
###xml 2869 2892 2869 2892 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">SARA total score (0&#8211;40)</th>
###xml 2892 2907 2892 2907 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="3">Tendon reflexes</th>
###xml 2907 2926 2907 2926 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Additional symptoms</th>
###xml 2926 2960 2926 2960 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Sensomotor axonal neuropathy (EMG)</th>
###xml 2960 3020 2960 3020 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Cerebellar vermis atrophy MRI/CT (disease duration in years)</th>
###xml 2654 3020 2654 3020 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="2">Family</th><th rowspan="2">Patient (M/F)</th><th rowspan="2">Age at onset (years)</th><th rowspan="2">Disease duration (years)</th><th rowspan="2">Disease stage<sup>31</sup></th><th rowspan="2">Gait spasticity</th><th rowspan="2">Lower body ataxia score (%)</th><th rowspan="2">Lower limb spasticity</th><th rowspan="2">Upper body ataxia score (%)</th><th rowspan="2">Upper limb spasticity</th><th rowspan="2">Remaining ataxia score (%)</th><th rowspan="2">SARA total score (0&#8211;40)</th><th colspan="3">Tendon reflexes</th><th rowspan="2">Additional symptoms</th><th rowspan="2">Sensomotor axonal neuropathy (EMG)</th><th rowspan="2">Cerebellar vermis atrophy MRI/CT (disease duration in years)</th></tr>
###xml 3020 3022 3020 3022 <th xmlns:xlink="http://www.w3.org/1999/xlink">UL</th>
###xml 3022 3026 3022 3026 <th xmlns:xlink="http://www.w3.org/1999/xlink">Knee</th>
###xml 3026 3031 3026 3031 <th xmlns:xlink="http://www.w3.org/1999/xlink">Ankle</th>
###xml 3020 3031 3020 3031 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>UL</th><th>Knee</th><th>Ankle</th></tr>
###xml 2654 3031 2654 3031 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="2">Family</th><th rowspan="2">Patient (M/F)</th><th rowspan="2">Age at onset (years)</th><th rowspan="2">Disease duration (years)</th><th rowspan="2">Disease stage<sup>31</sup></th><th rowspan="2">Gait spasticity</th><th rowspan="2">Lower body ataxia score (%)</th><th rowspan="2">Lower limb spasticity</th><th rowspan="2">Upper body ataxia score (%)</th><th rowspan="2">Upper limb spasticity</th><th rowspan="2">Remaining ataxia score (%)</th><th rowspan="2">SARA total score (0&#8211;40)</th><th colspan="3">Tendon reflexes</th><th rowspan="2">Additional symptoms</th><th rowspan="2">Sensomotor axonal neuropathy (EMG)</th><th rowspan="2">Cerebellar vermis atrophy MRI/CT (disease duration in years)</th></tr><tr><th>UL</th><th>Knee</th><th>Ankle</th></tr></thead>
###xml 3031 3032 3031 3032 <td xmlns:xlink="http://www.w3.org/1999/xlink">1</td>
###xml 3032 3036 3032 3036 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1(M)</td>
###xml 3036 3037 3036 3037 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3</td>
###xml 3037 3039 3037 3039 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">36</td>
###xml 3039 3040 3039 3040 <td xmlns:xlink="http://www.w3.org/1999/xlink">2</td>
###xml 3040 3043 3040 3043 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3043 3047 3043 3047 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">61.1</td>
###xml 3047 3050 3047 3050 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3050 3054 3050 3054 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">25.0</td>
###xml 3054 3055 3054 3055 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 3055 3057 3055 3057 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">30</td>
###xml 3057 3059 3057 3059 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">17</td>
###xml 3059 3060 3059 3060 <td xmlns:xlink="http://www.w3.org/1999/xlink">n</td>
###xml 3060 3061 3060 3061 <td xmlns:xlink="http://www.w3.org/1999/xlink">h</td>
###xml 3061 3062 3061 3062 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3062 3086 3062 3086 <td xmlns:xlink="http://www.w3.org/1999/xlink">dysphagia, urinary dysf.</td>
###xml 3086 3088 3086 3088 <td xmlns:xlink="http://www.w3.org/1999/xlink">nd</td>
###xml 3088 3101 3088 3101 <td xmlns:xlink="http://www.w3.org/1999/xlink">Moderate (29)</td>
###xml 3031 3101 3031 3101 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>1</td><td char="(" align="char">1(M)</td><td char="." align="char">3</td><td char="." align="char">36</td><td>2</td><td>+++</td><td char="." align="char">61.1</td><td>+++</td><td char="." align="char">25.0</td><td>&#8722;</td><td char="." align="char">30</td><td char="." align="char">17</td><td>n</td><td>h</td><td>a</td><td>dysphagia, urinary dysf.</td><td>nd</td><td>Moderate (29)</td></tr>
###xml 3101 3102 3101 3102 <td xmlns:xlink="http://www.w3.org/1999/xlink">2</td>
###xml 3102 3106 3102 3106 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2(F)</td>
###xml 3106 3107 3106 3107 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3</td>
###xml 3107 3109 3107 3109 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">42</td>
###xml 3109 3110 3109 3110 <td xmlns:xlink="http://www.w3.org/1999/xlink">3</td>
###xml 3110 3113 3110 3113 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3113 3117 3113 3117 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">83.3</td>
###xml 3117 3120 3117 3120 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3120 3124 3120 3124 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">37.5</td>
###xml 3124 3125 3124 3125 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 3125 3127 3125 3127 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">20</td>
###xml 3127 3131 3127 3131 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">21.5</td>
###xml 3131 3132 3131 3132 <td xmlns:xlink="http://www.w3.org/1999/xlink">n</td>
###xml 3132 3133 3132 3133 <td xmlns:xlink="http://www.w3.org/1999/xlink">h</td>
###xml 3133 3134 3133 3134 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3134 3134 3134 3134 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3134 3138 3134 3138 <td xmlns:xlink="http://www.w3.org/1999/xlink">+, D</td>
###xml 3138 3149 3138 3149 <td xmlns:xlink="http://www.w3.org/1999/xlink">Severe (35)</td>
###xml 3101 3149 3101 3149 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>2</td><td char="(" align="char">2(F)</td><td char="." align="char">3</td><td char="." align="char">42</td><td>3</td><td>+++</td><td char="." align="char">83.3</td><td>+++</td><td char="." align="char">37.5</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">21.5</td><td>n</td><td>h</td><td>a</td><td/><td>+, D</td><td>Severe (35)</td></tr>
###xml 3149 3150 3149 3150 <td xmlns:xlink="http://www.w3.org/1999/xlink">3</td>
###xml 3150 3154 3150 3154 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3(M)</td>
###xml 3154 3155 3154 3155 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8</td>
###xml 3155 3157 3155 3157 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">45</td>
###xml 3157 3158 3157 3158 <td xmlns:xlink="http://www.w3.org/1999/xlink">3</td>
###xml 3158 3161 3158 3161 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3161 3165 3161 3165 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">88.9</td>
###xml 3165 3168 3165 3168 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3168 3172 3168 3172 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">33.3</td>
###xml 3172 3173 3172 3173 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 3173 3175 3173 3175 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">10</td>
###xml 3175 3177 3175 3177 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">21</td>
###xml 3177 3178 3177 3178 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3178 3179 3178 3179 <td xmlns:xlink="http://www.w3.org/1999/xlink">n</td>
###xml 3179 3180 3179 3180 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3180 3193 3180 3193 <td xmlns:xlink="http://www.w3.org/1999/xlink">Urinary dysf.</td>
###xml 3193 3197 3193 3197 <td xmlns:xlink="http://www.w3.org/1999/xlink">+, D</td>
###xml 3197 3208 3197 3208 <td xmlns:xlink="http://www.w3.org/1999/xlink">Severe (27)</td>
###xml 3149 3208 3149 3208 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>3</td><td char="(" align="char">3(M)</td><td char="." align="char">8</td><td char="." align="char">45</td><td>3</td><td>+++</td><td char="." align="char">88.9</td><td>+++</td><td char="." align="char">33.3</td><td>&#8722;</td><td char="." align="char">10</td><td char="." align="char">21</td><td>a</td><td>n</td><td>a</td><td>Urinary dysf.</td><td>+, D</td><td>Severe (27)</td></tr>
###xml 3208 3209 3208 3209 <td xmlns:xlink="http://www.w3.org/1999/xlink">4</td>
###xml 3213 3214 3213 3214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 3209 3214 3209 3214 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4(F)<sup>a</sup></td>
###xml 3214 3215 3214 3215 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3</td>
###xml 3215 3217 3215 3217 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">33</td>
###xml 3217 3218 3217 3218 <td xmlns:xlink="http://www.w3.org/1999/xlink">3</td>
###xml 3218 3221 3218 3221 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3221 3225 3221 3225 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">94.4</td>
###xml 3225 3228 3225 3228 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3228 3232 3228 3232 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">33.3</td>
###xml 3232 3233 3232 3233 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 3233 3235 3233 3235 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">20</td>
###xml 3235 3237 3235 3237 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">23</td>
###xml 3237 3238 3237 3238 <td xmlns:xlink="http://www.w3.org/1999/xlink">n</td>
###xml 3238 3239 3238 3239 <td xmlns:xlink="http://www.w3.org/1999/xlink">n</td>
###xml 3239 3240 3239 3240 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3240 3253 3240 3253 <td xmlns:xlink="http://www.w3.org/1999/xlink">Urinary dysf.</td>
###xml 3253 3254 3253 3254 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 3254 3265 3254 3265 <td xmlns:xlink="http://www.w3.org/1999/xlink">Severe (24)</td>
###xml 3208 3265 3208 3265 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>4</td><td char="(" align="char">4(F)<sup>a</sup></td><td char="." align="char">3</td><td char="." align="char">33</td><td>3</td><td>+++</td><td char="." align="char">94.4</td><td>+++</td><td char="." align="char">33.3</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">23</td><td>n</td><td>n</td><td>a</td><td>Urinary dysf.</td><td>+</td><td>Severe (24)</td></tr>
###xml 3265 3266 3265 3266 <td xmlns:xlink="http://www.w3.org/1999/xlink">5</td>
###xml 3270 3271 3270 3271 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 3266 3271 3266 3271 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5(M)<sup>b</sup></td>
###xml 3271 3272 3271 3272 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5</td>
###xml 3272 3274 3272 3274 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">32</td>
###xml 3274 3275 3274 3275 <td xmlns:xlink="http://www.w3.org/1999/xlink">2</td>
###xml 3275 3275 3275 3275 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3275 3275 3275 3275 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3275 3275 3275 3275 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3275 3275 3275 3275 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3275 3275 3275 3275 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3275 3275 3275 3275 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3275 3275 3275 3275 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3275 3276 3275 3276 <td xmlns:xlink="http://www.w3.org/1999/xlink">n</td>
###xml 3276 3277 3276 3277 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3277 3278 3277 3278 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3278 3278 3278 3278 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3278 3280 3278 3280 <td xmlns:xlink="http://www.w3.org/1999/xlink">nd</td>
###xml 3280 3280 3280 3280 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3265 3280 3265 3280 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>5</td><td char="(" align="char">5(M)<sup>b</sup></td><td char="." align="char">5</td><td char="." align="char">32</td><td>2</td><td/><td char="." align="char"/><td/><td char="." align="char"/><td/><td char="." align="char"/><td char="." align="char"/><td>n</td><td>a</td><td>a</td><td/><td>nd</td><td/></tr>
###xml 3280 3281 3280 3281 <td xmlns:xlink="http://www.w3.org/1999/xlink">6</td>
###xml 3281 3285 3281 3285 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">6(F)</td>
###xml 3285 3286 3285 3286 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1</td>
###xml 3286 3288 3286 3288 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">39</td>
###xml 3288 3289 3288 3289 <td xmlns:xlink="http://www.w3.org/1999/xlink">3</td>
###xml 3289 3292 3289 3292 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3292 3296 3292 3296 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">86.1</td>
###xml 3296 3298 3296 3298 <td xmlns:xlink="http://www.w3.org/1999/xlink">++</td>
###xml 3298 3302 3298 3302 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">50.0</td>
###xml 3302 3303 3302 3303 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 3303 3305 3303 3305 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">20</td>
###xml 3305 3309 3305 3309 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">23.5</td>
###xml 3309 3310 3309 3310 <td xmlns:xlink="http://www.w3.org/1999/xlink">n</td>
###xml 3310 3311 3310 3311 <td xmlns:xlink="http://www.w3.org/1999/xlink">h</td>
###xml 3311 3312 3311 3312 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3312 3325 3312 3325 <td xmlns:xlink="http://www.w3.org/1999/xlink">Urinary dysf.</td>
###xml 3325 3326 3325 3326 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 3326 3339 3326 3339 <td xmlns:xlink="http://www.w3.org/1999/xlink">Moderate (34)</td>
###xml 3280 3339 3280 3339 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>6</td><td char="(" align="char">6(F)</td><td char="." align="char">1</td><td char="." align="char">39</td><td>3</td><td>+++</td><td char="." align="char">86.1</td><td>++</td><td char="." align="char">50.0</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">23.5</td><td>n</td><td>h</td><td>a</td><td>Urinary dysf.</td><td>+</td><td>Moderate (34)</td></tr>
###xml 3339 3340 3339 3340 <td xmlns:xlink="http://www.w3.org/1999/xlink">7</td>
###xml 3340 3344 3340 3344 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7(M)</td>
###xml 3344 3345 3344 3345 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1</td>
###xml 3345 3347 3345 3347 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">33</td>
###xml 3347 3348 3347 3348 <td xmlns:xlink="http://www.w3.org/1999/xlink">3</td>
###xml 3348 3351 3348 3351 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3351 3355 3351 3355 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">86.1</td>
###xml 3355 3357 3355 3357 <td xmlns:xlink="http://www.w3.org/1999/xlink">++</td>
###xml 3357 3361 3357 3361 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">41.7</td>
###xml 3361 3362 3361 3362 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 3362 3364 3362 3364 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">20</td>
###xml 3364 3368 3364 3368 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">22.5</td>
###xml 3368 3369 3368 3369 <td xmlns:xlink="http://www.w3.org/1999/xlink">n</td>
###xml 3369 3370 3369 3370 <td xmlns:xlink="http://www.w3.org/1999/xlink">h</td>
###xml 3370 3371 3370 3371 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3371 3371 3371 3371 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3371 3373 3371 3373 <td xmlns:xlink="http://www.w3.org/1999/xlink">nd</td>
###xml 3373 3386 3373 3386 <td xmlns:xlink="http://www.w3.org/1999/xlink">Moderate (24)</td>
###xml 3339 3386 3339 3386 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>7</td><td char="(" align="char">7(M)</td><td char="." align="char">1</td><td char="." align="char">33</td><td>3</td><td>+++</td><td char="." align="char">86.1</td><td>++</td><td char="." align="char">41.7</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">22.5</td><td>n</td><td>h</td><td>a</td><td/><td>nd</td><td>Moderate (24)</td></tr>
###xml 3386 3386 3386 3386 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3386 3390 3386 3390 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">8(F)</td>
###xml 3390 3391 3390 3391 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3</td>
###xml 3391 3393 3391 3393 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">28</td>
###xml 3393 3394 3393 3394 <td xmlns:xlink="http://www.w3.org/1999/xlink">3</td>
###xml 3394 3394 3394 3394 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3394 3394 3394 3394 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3394 3394 3394 3394 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3394 3394 3394 3394 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3394 3394 3394 3394 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3394 3394 3394 3394 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3394 3394 3394 3394 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3394 3394 3394 3394 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3394 3395 3394 3395 <td xmlns:xlink="http://www.w3.org/1999/xlink">h</td>
###xml 3395 3396 3395 3396 <td xmlns:xlink="http://www.w3.org/1999/xlink">h</td>
###xml 3396 3396 3396 3396 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3396 3398 3396 3398 <td xmlns:xlink="http://www.w3.org/1999/xlink">nd</td>
###xml 3398 3411 3398 3411 <td xmlns:xlink="http://www.w3.org/1999/xlink">Moderate (23)</td>
###xml 3386 3411 3386 3411 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char"/><td char="(" align="char">8(F)</td><td char="." align="char">3</td><td char="." align="char">28</td><td>3</td><td/><td char="." align="char"/><td/><td char="." align="char"/><td/><td char="." align="char"/><td char="." align="char"/><td/><td>h</td><td>h</td><td/><td>nd</td><td>Moderate (23)</td></tr>
###xml 3411 3412 3411 3412 <td xmlns:xlink="http://www.w3.org/1999/xlink">8</td>
###xml 3412 3416 3412 3416 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">9(M)</td>
###xml 3416 3417 3416 3417 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1</td>
###xml 3417 3419 3417 3419 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">26</td>
###xml 3419 3420 3419 3420 <td xmlns:xlink="http://www.w3.org/1999/xlink">2</td>
###xml 3420 3423 3420 3423 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3423 3427 3423 3427 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">66.7</td>
###xml 3427 3430 3427 3430 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3430 3434 3430 3434 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">37.5</td>
###xml 3434 3435 3434 3435 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 3435 3437 3435 3437 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">30</td>
###xml 3437 3441 3437 3441 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">19.5</td>
###xml 3441 3442 3441 3442 <td xmlns:xlink="http://www.w3.org/1999/xlink">n</td>
###xml 3442 3443 3442 3443 <td xmlns:xlink="http://www.w3.org/1999/xlink">h</td>
###xml 3443 3444 3443 3444 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3444 3486 3444 3486 <td xmlns:xlink="http://www.w3.org/1999/xlink">Cystic kidney right, dystonic posturing UL</td>
###xml 3486 3490 3486 3490 <td xmlns:xlink="http://www.w3.org/1999/xlink">+, D</td>
###xml 3490 3499 3490 3499 <td xmlns:xlink="http://www.w3.org/1999/xlink">Mild (17)</td>
###xml 3411 3499 3411 3499 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>8</td><td char="(" align="char">9(M)</td><td char="." align="char">1</td><td char="." align="char">26</td><td>2</td><td>+++</td><td char="." align="char">66.7</td><td>+++</td><td char="." align="char">37.5</td><td>+</td><td char="." align="char">30</td><td char="." align="char">19.5</td><td>n</td><td>h</td><td>a</td><td>Cystic kidney right, dystonic posturing UL</td><td>+, D</td><td>Mild (17)</td></tr>
###xml 3499 3500 3499 3500 <td xmlns:xlink="http://www.w3.org/1999/xlink">9</td>
###xml 3500 3505 3500 3505 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">10(F)</td>
###xml 3505 3506 3505 3506 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2</td>
###xml 3506 3508 3506 3508 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">27</td>
###xml 3508 3509 3508 3509 <td xmlns:xlink="http://www.w3.org/1999/xlink">3</td>
###xml 3509 3512 3509 3512 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3512 3515 3512 3515 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">100</td>
###xml 3515 3518 3515 3518 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3518 3522 3518 3522 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">33.3</td>
###xml 3522 3523 3522 3523 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 3523 3525 3523 3525 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">10</td>
###xml 3525 3527 3525 3527 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">23</td>
###xml 3527 3528 3527 3528 <td xmlns:xlink="http://www.w3.org/1999/xlink">n</td>
###xml 3528 3529 3528 3529 <td xmlns:xlink="http://www.w3.org/1999/xlink">n</td>
###xml 3529 3530 3529 3530 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3530 3543 3530 3543 <td xmlns:xlink="http://www.w3.org/1999/xlink">Urinary dysf.</td>
###xml 3543 3544 3543 3544 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 3544 3557 3544 3557 <td xmlns:xlink="http://www.w3.org/1999/xlink">Moderate (18)</td>
###xml 3499 3557 3499 3557 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>9</td><td char="(" align="char">10(F)</td><td char="." align="char">2</td><td char="." align="char">27</td><td>3</td><td>+++</td><td char="." align="char">100</td><td>+++</td><td char="." align="char">33.3</td><td>&#8722;</td><td char="." align="char">10</td><td char="." align="char">23</td><td>n</td><td>n</td><td>a</td><td>Urinary dysf.</td><td>+</td><td>Moderate (18)</td></tr>
###xml 3557 3557 3557 3557 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3557 3562 3557 3562 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">11(F)</td>
###xml 3562 3563 3562 3563 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1</td>
###xml 3563 3565 3563 3565 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">25</td>
###xml 3565 3566 3565 3566 <td xmlns:xlink="http://www.w3.org/1999/xlink">3</td>
###xml 3566 3569 3566 3569 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3569 3572 3569 3572 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">100</td>
###xml 3572 3575 3572 3575 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3575 3579 3575 3579 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">41.7</td>
###xml 3579 3580 3579 3580 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 3580 3582 3580 3582 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">40</td>
###xml 3582 3584 3582 3584 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">27</td>
###xml 3584 3585 3584 3585 <td xmlns:xlink="http://www.w3.org/1999/xlink">h</td>
###xml 3585 3586 3585 3586 <td xmlns:xlink="http://www.w3.org/1999/xlink">h</td>
###xml 3586 3587 3586 3587 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3587 3613 3587 3613 <td xmlns:xlink="http://www.w3.org/1999/xlink">Urinary dysf., dystonia UL</td>
###xml 3613 3615 3613 3615 <td xmlns:xlink="http://www.w3.org/1999/xlink">nd</td>
###xml 3615 3617 3615 3617 <td xmlns:xlink="http://www.w3.org/1999/xlink">nk</td>
###xml 3557 3617 3557 3617 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char"/><td char="(" align="char">11(F)</td><td char="." align="char">1</td><td char="." align="char">25</td><td>3</td><td>+++</td><td char="." align="char">100</td><td>+++</td><td char="." align="char">41.7</td><td>&#8722;</td><td char="." align="char">40</td><td char="." align="char">27</td><td>h</td><td>h</td><td>a</td><td>Urinary dysf., dystonia UL</td><td>nd</td><td>nk</td></tr>
###xml 3617 3617 3617 3617 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3617 3622 3617 3622 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">12(M)</td>
###xml 3622 3623 3622 3623 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1</td>
###xml 3623 3625 3623 3625 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">25</td>
###xml 3625 3626 3625 3626 <td xmlns:xlink="http://www.w3.org/1999/xlink">3</td>
###xml 3626 3629 3626 3629 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3629 3633 3629 3633 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">63.9</td>
###xml 3633 3635 3633 3635 <td xmlns:xlink="http://www.w3.org/1999/xlink">++</td>
###xml 3635 3639 3635 3639 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">41.7</td>
###xml 3639 3640 3639 3640 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 3640 3642 3640 3642 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">30</td>
###xml 3642 3646 3642 3646 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">19.5</td>
###xml 3646 3647 3646 3647 <td xmlns:xlink="http://www.w3.org/1999/xlink">n</td>
###xml 3647 3648 3647 3648 <td xmlns:xlink="http://www.w3.org/1999/xlink">n</td>
###xml 3648 3649 3648 3649 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3649 3678 3649 3678 <td xmlns:xlink="http://www.w3.org/1999/xlink">Dystonia neck + UL, dysphagia</td>
###xml 3678 3679 3678 3679 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 3679 3688 3679 3688 <td xmlns:xlink="http://www.w3.org/1999/xlink">Mild (12)</td>
###xml 3617 3688 3617 3688 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char"/><td char="(" align="char">12(M)</td><td char="." align="char">1</td><td char="." align="char">25</td><td>3</td><td>+++</td><td char="." align="char">63.9</td><td>++</td><td char="." align="char">41.7</td><td>+</td><td char="." align="char">30</td><td char="." align="char">19.5</td><td>n</td><td>n</td><td>a</td><td>Dystonia neck + UL, dysphagia</td><td>+</td><td>Mild (12)</td></tr>
###xml 3688 3690 3688 3690 <td xmlns:xlink="http://www.w3.org/1999/xlink">10</td>
###xml 3690 3695 3690 3695 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">13(F)</td>
###xml 3695 3696 3695 3696 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2</td>
###xml 3696 3698 3696 3698 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">29</td>
###xml 3698 3699 3698 3699 <td xmlns:xlink="http://www.w3.org/1999/xlink">2</td>
###xml 3699 3702 3699 3702 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3702 3706 3702 3706 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">44.4</td>
###xml 3706 3708 3706 3708 <td xmlns:xlink="http://www.w3.org/1999/xlink">++</td>
###xml 3708 3712 3708 3712 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">33.3</td>
###xml 3712 3713 3712 3713 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 3713 3715 3713 3715 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">20</td>
###xml 3715 3717 3715 3717 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">14</td>
###xml 3717 3718 3717 3718 <td xmlns:xlink="http://www.w3.org/1999/xlink">n</td>
###xml 3718 3719 3718 3719 <td xmlns:xlink="http://www.w3.org/1999/xlink">h</td>
###xml 3719 3720 3719 3720 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3720 3739 3720 3739 <td xmlns:xlink="http://www.w3.org/1999/xlink">Urinary dysfunction</td>
###xml 3739 3740 3739 3740 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 3740 3742 3740 3742 <td xmlns:xlink="http://www.w3.org/1999/xlink">nk</td>
###xml 3688 3742 3688 3742 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>10</td><td char="(" align="char">13(F)</td><td char="." align="char">2</td><td char="." align="char">29</td><td>2</td><td>+++</td><td char="." align="char">44.4</td><td>++</td><td char="." align="char">33.3</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">14</td><td>n</td><td>h</td><td>a</td><td>Urinary dysfunction</td><td>+</td><td>nk</td></tr>
###xml 3742 3742 3742 3742 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3742 3747 3742 3747 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">14(F)</td>
###xml 3747 3748 3747 3748 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3</td>
###xml 3748 3750 3748 3750 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">31</td>
###xml 3750 3751 3750 3751 <td xmlns:xlink="http://www.w3.org/1999/xlink">2</td>
###xml 3751 3753 3751 3753 <td xmlns:xlink="http://www.w3.org/1999/xlink">++</td>
###xml 3753 3757 3753 3757 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">38.9</td>
###xml 3757 3758 3757 3758 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 3758 3762 3758 3762 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">45.8</td>
###xml 3762 3763 3762 3763 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 3763 3765 3763 3765 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">40</td>
###xml 3765 3769 3765 3769 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">16.5</td>
###xml 3769 3770 3769 3770 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3770 3771 3770 3771 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3771 3772 3771 3772 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3772 3781 3772 3781 <td xmlns:xlink="http://www.w3.org/1999/xlink">Dysphagia</td>
###xml 3781 3785 3781 3785 <td xmlns:xlink="http://www.w3.org/1999/xlink">+, D</td>
###xml 3785 3787 3785 3787 <td xmlns:xlink="http://www.w3.org/1999/xlink">nk</td>
###xml 3742 3787 3742 3787 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char"/><td char="(" align="char">14(F)</td><td char="." align="char">3</td><td char="." align="char">31</td><td>2</td><td>++</td><td char="." align="char">38.9</td><td>+</td><td char="." align="char">45.8</td><td>&#8722;</td><td char="." align="char">40</td><td char="." align="char">16.5</td><td>a</td><td>a</td><td>a</td><td>Dysphagia</td><td>+, D</td><td>nk</td></tr>
###xml 3787 3789 3787 3789 <td xmlns:xlink="http://www.w3.org/1999/xlink">11</td>
###xml 3789 3794 3789 3794 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">15(M)</td>
###xml 3794 3796 3794 3796 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">12</td>
###xml 3796 3798 3796 3798 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">39</td>
###xml 3798 3799 3798 3799 <td xmlns:xlink="http://www.w3.org/1999/xlink">3</td>
###xml 3799 3801 3799 3801 <td xmlns:xlink="http://www.w3.org/1999/xlink">na</td>
###xml 3801 3804 3801 3804 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">100</td>
###xml 3804 3807 3804 3807 <td xmlns:xlink="http://www.w3.org/1999/xlink">+++</td>
###xml 3807 3811 3807 3811 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">58.3</td>
###xml 3811 3812 3811 3812 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 3812 3814 3812 3814 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">70</td>
###xml 3814 3816 3814 3816 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">28</td>
###xml 3816 3817 3816 3817 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3817 3818 3817 3818 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3818 3819 3818 3819 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3819 3843 3819 3843 <td xmlns:xlink="http://www.w3.org/1999/xlink">Dysphagia, urinary dysf.</td>
###xml 3843 3845 3843 3845 <td xmlns:xlink="http://www.w3.org/1999/xlink">nd</td>
###xml 3845 3856 3845 3856 <td xmlns:xlink="http://www.w3.org/1999/xlink">Severe (30)</td>
###xml 3787 3856 3787 3856 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>11</td><td char="(" align="char">15(M)</td><td char="." align="char">12</td><td char="." align="char">39</td><td>3</td><td>na</td><td char="." align="char">100</td><td>+++</td><td char="." align="char">58.3</td><td>+</td><td char="." align="char">70</td><td char="." align="char">28</td><td>a</td><td>a</td><td>a</td><td>Dysphagia, urinary dysf.</td><td>nd</td><td>Severe (30)</td></tr>
###xml 3856 3856 3856 3856 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3856 3861 3856 3861 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">16(M)</td>
###xml 3861 3862 3861 3862 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6</td>
###xml 3862 3864 3862 3864 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">41</td>
###xml 3864 3865 3864 3865 <td xmlns:xlink="http://www.w3.org/1999/xlink">2</td>
###xml 3865 3867 3865 3867 <td xmlns:xlink="http://www.w3.org/1999/xlink">++</td>
###xml 3867 3871 3867 3871 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">61.1</td>
###xml 3871 3873 3871 3873 <td xmlns:xlink="http://www.w3.org/1999/xlink">++</td>
###xml 3873 3877 3873 3877 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">37.5</td>
###xml 3877 3878 3877 3878 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 3878 3880 3878 3880 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">10</td>
###xml 3880 3884 3880 3884 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">16.5</td>
###xml 3884 3885 3884 3885 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3885 3886 3885 3886 <td xmlns:xlink="http://www.w3.org/1999/xlink">n</td>
###xml 3886 3887 3886 3887 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3887 3918 3887 3918 <td xmlns:xlink="http://www.w3.org/1999/xlink">impairment, diabetes, dysphagia</td>
###xml 3918 3920 3918 3920 <td xmlns:xlink="http://www.w3.org/1999/xlink">nd</td>
###xml 3920 3931 3920 3931 <td xmlns:xlink="http://www.w3.org/1999/xlink">Severe (38)</td>
###xml 3856 3931 3856 3931 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char"/><td char="(" align="char">16(M)</td><td char="." align="char">6</td><td char="." align="char">41</td><td>2</td><td>++</td><td char="." align="char">61.1</td><td>++</td><td char="." align="char">37.5</td><td>&#8722;</td><td char="." align="char">10</td><td char="." align="char">16.5</td><td>a</td><td>n</td><td>a</td><td>impairment, diabetes, dysphagia</td><td>nd</td><td>Severe (38)</td></tr>
###xml 3931 3933 3931 3933 <td xmlns:xlink="http://www.w3.org/1999/xlink">12</td>
###xml 3933 3938 3933 3938 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">17(F)</td>
###xml 3938 3938 3938 3938 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3938 3938 3938 3938 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3938 3938 3938 3938 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3938 3938 3938 3938 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3938 3938 3938 3938 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3938 3938 3938 3938 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3938 3938 3938 3938 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3938 3938 3938 3938 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3938 3938 3938 3938 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3938 3938 3938 3938 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3938 3938 3938 3938 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3938 3938 3938 3938 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3938 3938 3938 3938 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3938 3938 3938 3938 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3938 3938 3938 3938 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3938 3938 3938 3938 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3931 3938 3931 3938 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>12</td><td char="(" align="char">17(F)</td><td char="." align="char"/><td char="." align="char"/><td/><td/><td char="." align="char"/><td/><td char="." align="char"/><td/><td char="." align="char"/><td char="." align="char"/><td/><td/><td/><td/><td/><td/></tr>
###xml 3938 3938 3938 3938 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3938 3943 3938 3943 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">18(F)</td>
###xml 3943 3943 3943 3943 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3943 3943 3943 3943 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3943 3943 3943 3943 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3943 3943 3943 3943 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3943 3943 3943 3943 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3943 3943 3943 3943 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3943 3943 3943 3943 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3943 3943 3943 3943 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3943 3943 3943 3943 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3943 3943 3943 3943 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 3943 3943 3943 3943 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3943 3943 3943 3943 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3943 3943 3943 3943 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3943 3943 3943 3943 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3943 3943 3943 3943 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3943 3943 3943 3943 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 3938 3943 3938 3943 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char"/><td char="(" align="char">18(F)</td><td char="." align="char"/><td char="." align="char"/><td/><td/><td char="." align="char"/><td/><td char="." align="char"/><td/><td char="." align="char"/><td char="." align="char"/><td/><td/><td/><td/><td/><td/></tr>
###xml 3943 3945 3943 3945 <td xmlns:xlink="http://www.w3.org/1999/xlink">13</td>
###xml 3950 3951 3950 3951 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 3945 3951 3945 3951 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">19(M)<sup>a</sup></td>
###xml 3951 3952 3951 3952 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2</td>
###xml 3952 3954 3952 3954 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">56</td>
###xml 3954 3955 3954 3955 <td xmlns:xlink="http://www.w3.org/1999/xlink">3</td>
###xml 3955 3957 3955 3957 <td xmlns:xlink="http://www.w3.org/1999/xlink">na</td>
###xml 3957 3960 3957 3960 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">100</td>
###xml 3960 3962 3960 3962 <td xmlns:xlink="http://www.w3.org/1999/xlink">++</td>
###xml 3962 3966 3962 3966 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">54.2</td>
###xml 3966 3967 3966 3967 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 3967 3969 3967 3969 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">70</td>
###xml 3969 3973 3969 3973 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">31.5</td>
###xml 3973 3974 3973 3974 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3974 3975 3974 3975 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3975 3976 3975 3976 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 3976 4000 3976 4000 <td xmlns:xlink="http://www.w3.org/1999/xlink">dysphagia, urinary dysf.</td>
###xml 4000 4003 4000 4003 <td xmlns:xlink="http://www.w3.org/1999/xlink">+,D</td>
###xml 4003 4014 4003 4014 <td xmlns:xlink="http://www.w3.org/1999/xlink">Severe (38)</td>
###xml 3943 4014 3943 4014 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>13</td><td char="(" align="char">19(M)<sup>a</sup></td><td char="." align="char">2</td><td char="." align="char">56</td><td>3</td><td>na</td><td char="." align="char">100</td><td>++</td><td char="." align="char">54.2</td><td>+</td><td char="." align="char">70</td><td char="." align="char">31.5</td><td>a</td><td>a</td><td>a</td><td>dysphagia, urinary dysf.</td><td>+,D</td><td>Severe (38)</td></tr>
###xml 4014 4014 4014 4014 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 4014 4019 4014 4019 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">20(M)</td>
###xml 4019 4020 4019 4020 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1</td>
###xml 4020 4022 4020 4022 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">56</td>
###xml 4022 4023 4022 4023 <td xmlns:xlink="http://www.w3.org/1999/xlink">3</td>
###xml 4023 4025 4023 4025 <td xmlns:xlink="http://www.w3.org/1999/xlink">na</td>
###xml 4025 4028 4025 4028 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">100</td>
###xml 4028 4030 4028 4030 <td xmlns:xlink="http://www.w3.org/1999/xlink">na</td>
###xml 4030 4034 4030 4034 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">54.2</td>
###xml 4034 4036 4034 4036 <td xmlns:xlink="http://www.w3.org/1999/xlink">na</td>
###xml 4036 4038 4036 4038 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">60</td>
###xml 4038 4042 4038 4042 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">30.5</td>
###xml 4042 4043 4042 4043 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 4043 4044 4043 4044 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 4044 4045 4044 4045 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 4045 4090 4045 4090 <td xmlns:xlink="http://www.w3.org/1999/xlink">Dysphagia, urinary dysf. cognitive impairment</td>
###xml 4090 4094 4090 4094 <td xmlns:xlink="http://www.w3.org/1999/xlink">+, D</td>
###xml 4094 4105 4094 4105 <td xmlns:xlink="http://www.w3.org/1999/xlink">Severe (48)</td>
###xml 4014 4105 4014 4105 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td char="." align="char"/><td char="(" align="char">20(M)</td><td char="." align="char">1</td><td char="." align="char">56</td><td>3</td><td>na</td><td char="." align="char">100</td><td>na</td><td char="." align="char">54.2</td><td>na</td><td char="." align="char">60</td><td char="." align="char">30.5</td><td>a</td><td>a</td><td>a</td><td>Dysphagia, urinary dysf. cognitive impairment</td><td>+, D</td><td>Severe (48)</td></tr>
###xml 4105 4107 4105 4107 <td xmlns:xlink="http://www.w3.org/1999/xlink">14</td>
###xml 4107 4112 4107 4112 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">21(M)</td>
###xml 4112 4115 4112 4115 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&lt;10</td>
###xml 4115 4117 4115 4117 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">26</td>
###xml 4117 4117 4117 4117 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 4117 4118 4117 4118 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 4118 4118 4118 4118 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 4118 4118 4118 4118 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 4118 4118 4118 4118 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 4118 4119 4118 4119 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 4119 4119 4119 4119 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 4119 4119 4119 4119 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 4119 4119 4119 4119 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 4119 4119 4119 4119 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 4119 4119 4119 4119 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 4119 4136 4119 4136 <td xmlns:xlink="http://www.w3.org/1999/xlink">Steatosis hepatis</td>
###xml 4136 4136 4136 4136 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 4136 4136 4136 4136 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 4105 4136 4105 4136 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>14</td><td char="(" align="char">21(M)</td><td char="." align="char">&lt;10</td><td char="." align="char">26</td><td/><td>+</td><td char="." align="char"/><td/><td char="." align="char"/><td>&#8722;</td><td char="." align="char"/><td char="." align="char"/><td/><td/><td/><td>Steatosis hepatis</td><td/><td/></tr>
###xml 4136 4138 4136 4138 <td xmlns:xlink="http://www.w3.org/1999/xlink">15</td>
###xml 4138 4143 4138 4143 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">22(F)</td>
###xml 4143 4144 4143 4144 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3</td>
###xml 4144 4146 4144 4146 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">53</td>
###xml 4146 4147 4146 4147 <td xmlns:xlink="http://www.w3.org/1999/xlink">3</td>
###xml 4147 4148 4147 4148 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 4148 4148 4148 4148 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 4148 4149 4148 4149 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 4149 4149 4149 4149 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 4149 4150 4149 4150 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 4150 4150 4150 4150 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 4150 4150 4150 4150 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 4150 4151 4150 4151 <td xmlns:xlink="http://www.w3.org/1999/xlink">l</td>
###xml 4151 4152 4151 4152 <td xmlns:xlink="http://www.w3.org/1999/xlink">n</td>
###xml 4152 4153 4152 4153 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 4153 4172 4153 4172 <td xmlns:xlink="http://www.w3.org/1999/xlink">Urinary dysfunction</td>
###xml 4172 4176 4172 4176 <td xmlns:xlink="http://www.w3.org/1999/xlink">+, D</td>
###xml 4176 4187 4176 4187 <td xmlns:xlink="http://www.w3.org/1999/xlink">Severe (53)</td>
###xml 4136 4187 4136 4187 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>15</td><td char="(" align="char">22(F)</td><td char="." align="char">3</td><td char="." align="char">53</td><td>3</td><td>+</td><td char="." align="char"/><td>+</td><td char="." align="char"/><td>&#8722;</td><td char="." align="char"/><td char="." align="char"/><td>l</td><td>n</td><td>a</td><td>Urinary dysfunction</td><td>+, D</td><td>Severe (53)</td></tr>
###xml 4187 4189 4187 4189 <td xmlns:xlink="http://www.w3.org/1999/xlink">16</td>
###xml 4194 4195 4194 4195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 4189 4195 4189 4195 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">23(M)<sup>b</sup></td>
###xml 4195 4196 4195 4196 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">9</td>
###xml 4196 4198 4196 4198 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">40</td>
###xml 4198 4200 4198 4200 <td xmlns:xlink="http://www.w3.org/1999/xlink">nk</td>
###xml 4200 4201 4200 4201 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 4201 4201 4201 4201 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 4201 4202 4201 4202 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 4202 4202 4202 4202 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 4202 4204 4202 4204 <td xmlns:xlink="http://www.w3.org/1999/xlink">Nk</td>
###xml 4204 4204 4204 4204 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 4204 4204 4204 4204 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 4204 4206 4204 4206 <td xmlns:xlink="http://www.w3.org/1999/xlink">nk</td>
###xml 4206 4207 4206 4207 <td xmlns:xlink="http://www.w3.org/1999/xlink">b</td>
###xml 4207 4208 4207 4208 <td xmlns:xlink="http://www.w3.org/1999/xlink">a</td>
###xml 4208 4210 4208 4210 <td xmlns:xlink="http://www.w3.org/1999/xlink">nk</td>
###xml 4210 4211 4210 4211 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 4211 4213 4211 4213 <td xmlns:xlink="http://www.w3.org/1999/xlink">nk</td>
###xml 4187 4213 4187 4213 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>16</td><td char="(" align="char">23(M)<sup>b</sup></td><td char="." align="char">9</td><td char="." align="char">40</td><td>nk</td><td>+</td><td/><td>+</td><td char="." align="char"/><td>Nk</td><td char="." align="char"/><td char="." align="char"/><td>nk</td><td>b</td><td>a</td><td>nk</td><td>+</td><td>nk</td></tr>
###xml 3031 4213 3031 4213 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>1</td><td char="(" align="char">1(M)</td><td char="." align="char">3</td><td char="." align="char">36</td><td>2</td><td>+++</td><td char="." align="char">61.1</td><td>+++</td><td char="." align="char">25.0</td><td>&#8722;</td><td char="." align="char">30</td><td char="." align="char">17</td><td>n</td><td>h</td><td>a</td><td>dysphagia, urinary dysf.</td><td>nd</td><td>Moderate (29)</td></tr><tr><td>2</td><td char="(" align="char">2(F)</td><td char="." align="char">3</td><td char="." align="char">42</td><td>3</td><td>+++</td><td char="." align="char">83.3</td><td>+++</td><td char="." align="char">37.5</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">21.5</td><td>n</td><td>h</td><td>a</td><td/><td>+, D</td><td>Severe (35)</td></tr><tr><td>3</td><td char="(" align="char">3(M)</td><td char="." align="char">8</td><td char="." align="char">45</td><td>3</td><td>+++</td><td char="." align="char">88.9</td><td>+++</td><td char="." align="char">33.3</td><td>&#8722;</td><td char="." align="char">10</td><td char="." align="char">21</td><td>a</td><td>n</td><td>a</td><td>Urinary dysf.</td><td>+, D</td><td>Severe (27)</td></tr><tr><td>4</td><td char="(" align="char">4(F)<sup>a</sup></td><td char="." align="char">3</td><td char="." align="char">33</td><td>3</td><td>+++</td><td char="." align="char">94.4</td><td>+++</td><td char="." align="char">33.3</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">23</td><td>n</td><td>n</td><td>a</td><td>Urinary dysf.</td><td>+</td><td>Severe (24)</td></tr><tr><td>5</td><td char="(" align="char">5(M)<sup>b</sup></td><td char="." align="char">5</td><td char="." align="char">32</td><td>2</td><td/><td char="." align="char"/><td/><td char="." align="char"/><td/><td char="." align="char"/><td char="." align="char"/><td>n</td><td>a</td><td>a</td><td/><td>nd</td><td/></tr><tr><td>6</td><td char="(" align="char">6(F)</td><td char="." align="char">1</td><td char="." align="char">39</td><td>3</td><td>+++</td><td char="." align="char">86.1</td><td>++</td><td char="." align="char">50.0</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">23.5</td><td>n</td><td>h</td><td>a</td><td>Urinary dysf.</td><td>+</td><td>Moderate (34)</td></tr><tr><td>7</td><td char="(" align="char">7(M)</td><td char="." align="char">1</td><td char="." align="char">33</td><td>3</td><td>+++</td><td char="." align="char">86.1</td><td>++</td><td char="." align="char">41.7</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">22.5</td><td>n</td><td>h</td><td>a</td><td/><td>nd</td><td>Moderate (24)</td></tr><tr><td char="." align="char"/><td char="(" align="char">8(F)</td><td char="." align="char">3</td><td char="." align="char">28</td><td>3</td><td/><td char="." align="char"/><td/><td char="." align="char"/><td/><td char="." align="char"/><td char="." align="char"/><td/><td>h</td><td>h</td><td/><td>nd</td><td>Moderate (23)</td></tr><tr><td>8</td><td char="(" align="char">9(M)</td><td char="." align="char">1</td><td char="." align="char">26</td><td>2</td><td>+++</td><td char="." align="char">66.7</td><td>+++</td><td char="." align="char">37.5</td><td>+</td><td char="." align="char">30</td><td char="." align="char">19.5</td><td>n</td><td>h</td><td>a</td><td>Cystic kidney right, dystonic posturing UL</td><td>+, D</td><td>Mild (17)</td></tr><tr><td>9</td><td char="(" align="char">10(F)</td><td char="." align="char">2</td><td char="." align="char">27</td><td>3</td><td>+++</td><td char="." align="char">100</td><td>+++</td><td char="." align="char">33.3</td><td>&#8722;</td><td char="." align="char">10</td><td char="." align="char">23</td><td>n</td><td>n</td><td>a</td><td>Urinary dysf.</td><td>+</td><td>Moderate (18)</td></tr><tr><td char="." align="char"/><td char="(" align="char">11(F)</td><td char="." align="char">1</td><td char="." align="char">25</td><td>3</td><td>+++</td><td char="." align="char">100</td><td>+++</td><td char="." align="char">41.7</td><td>&#8722;</td><td char="." align="char">40</td><td char="." align="char">27</td><td>h</td><td>h</td><td>a</td><td>Urinary dysf., dystonia UL</td><td>nd</td><td>nk</td></tr><tr><td char="." align="char"/><td char="(" align="char">12(M)</td><td char="." align="char">1</td><td char="." align="char">25</td><td>3</td><td>+++</td><td char="." align="char">63.9</td><td>++</td><td char="." align="char">41.7</td><td>+</td><td char="." align="char">30</td><td char="." align="char">19.5</td><td>n</td><td>n</td><td>a</td><td>Dystonia neck + UL, dysphagia</td><td>+</td><td>Mild (12)</td></tr><tr><td>10</td><td char="(" align="char">13(F)</td><td char="." align="char">2</td><td char="." align="char">29</td><td>2</td><td>+++</td><td char="." align="char">44.4</td><td>++</td><td char="." align="char">33.3</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">14</td><td>n</td><td>h</td><td>a</td><td>Urinary dysfunction</td><td>+</td><td>nk</td></tr><tr><td char="." align="char"/><td char="(" align="char">14(F)</td><td char="." align="char">3</td><td char="." align="char">31</td><td>2</td><td>++</td><td char="." align="char">38.9</td><td>+</td><td char="." align="char">45.8</td><td>&#8722;</td><td char="." align="char">40</td><td char="." align="char">16.5</td><td>a</td><td>a</td><td>a</td><td>Dysphagia</td><td>+, D</td><td>nk</td></tr><tr><td>11</td><td char="(" align="char">15(M)</td><td char="." align="char">12</td><td char="." align="char">39</td><td>3</td><td>na</td><td char="." align="char">100</td><td>+++</td><td char="." align="char">58.3</td><td>+</td><td char="." align="char">70</td><td char="." align="char">28</td><td>a</td><td>a</td><td>a</td><td>Dysphagia, urinary dysf.</td><td>nd</td><td>Severe (30)</td></tr><tr><td char="." align="char"/><td char="(" align="char">16(M)</td><td char="." align="char">6</td><td char="." align="char">41</td><td>2</td><td>++</td><td char="." align="char">61.1</td><td>++</td><td char="." align="char">37.5</td><td>&#8722;</td><td char="." align="char">10</td><td char="." align="char">16.5</td><td>a</td><td>n</td><td>a</td><td>impairment, diabetes, dysphagia</td><td>nd</td><td>Severe (38)</td></tr><tr><td>12</td><td char="(" align="char">17(F)</td><td char="." align="char"/><td char="." align="char"/><td/><td/><td char="." align="char"/><td/><td char="." align="char"/><td/><td char="." align="char"/><td char="." align="char"/><td/><td/><td/><td/><td/><td/></tr><tr><td char="." align="char"/><td char="(" align="char">18(F)</td><td char="." align="char"/><td char="." align="char"/><td/><td/><td char="." align="char"/><td/><td char="." align="char"/><td/><td char="." align="char"/><td char="." align="char"/><td/><td/><td/><td/><td/><td/></tr><tr><td>13</td><td char="(" align="char">19(M)<sup>a</sup></td><td char="." align="char">2</td><td char="." align="char">56</td><td>3</td><td>na</td><td char="." align="char">100</td><td>++</td><td char="." align="char">54.2</td><td>+</td><td char="." align="char">70</td><td char="." align="char">31.5</td><td>a</td><td>a</td><td>a</td><td>dysphagia, urinary dysf.</td><td>+,D</td><td>Severe (38)</td></tr><tr><td char="." align="char"/><td char="(" align="char">20(M)</td><td char="." align="char">1</td><td char="." align="char">56</td><td>3</td><td>na</td><td char="." align="char">100</td><td>na</td><td char="." align="char">54.2</td><td>na</td><td char="." align="char">60</td><td char="." align="char">30.5</td><td>a</td><td>a</td><td>a</td><td>Dysphagia, urinary dysf. cognitive impairment</td><td>+, D</td><td>Severe (48)</td></tr><tr><td>14</td><td char="(" align="char">21(M)</td><td char="." align="char">&lt;10</td><td char="." align="char">26</td><td/><td>+</td><td char="." align="char"/><td/><td char="." align="char"/><td>&#8722;</td><td char="." align="char"/><td char="." align="char"/><td/><td/><td/><td>Steatosis hepatis</td><td/><td/></tr><tr><td>15</td><td char="(" align="char">22(F)</td><td char="." align="char">3</td><td char="." align="char">53</td><td>3</td><td>+</td><td char="." align="char"/><td>+</td><td char="." align="char"/><td>&#8722;</td><td char="." align="char"/><td char="." align="char"/><td>l</td><td>n</td><td>a</td><td>Urinary dysfunction</td><td>+, D</td><td>Severe (53)</td></tr><tr><td>16</td><td char="(" align="char">23(M)<sup>b</sup></td><td char="." align="char">9</td><td char="." align="char">40</td><td>nk</td><td>+</td><td/><td>+</td><td char="." align="char"/><td>Nk</td><td char="." align="char"/><td char="." align="char"/><td>nk</td><td>b</td><td>a</td><td>nk</td><td>+</td><td>nk</td></tr></tbody>
###xml 2654 4213 2654 4213 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="2">Family</th><th rowspan="2">Patient (M/F)</th><th rowspan="2">Age at onset (years)</th><th rowspan="2">Disease duration (years)</th><th rowspan="2">Disease stage<sup>31</sup></th><th rowspan="2">Gait spasticity</th><th rowspan="2">Lower body ataxia score (%)</th><th rowspan="2">Lower limb spasticity</th><th rowspan="2">Upper body ataxia score (%)</th><th rowspan="2">Upper limb spasticity</th><th rowspan="2">Remaining ataxia score (%)</th><th rowspan="2">SARA total score (0&#8211;40)</th><th colspan="3">Tendon reflexes</th><th rowspan="2">Additional symptoms</th><th rowspan="2">Sensomotor axonal neuropathy (EMG)</th><th rowspan="2">Cerebellar vermis atrophy MRI/CT (disease duration in years)</th></tr><tr><th>UL</th><th>Knee</th><th>Ankle</th></tr></thead><tbody><tr><td>1</td><td char="(" align="char">1(M)</td><td char="." align="char">3</td><td char="." align="char">36</td><td>2</td><td>+++</td><td char="." align="char">61.1</td><td>+++</td><td char="." align="char">25.0</td><td>&#8722;</td><td char="." align="char">30</td><td char="." align="char">17</td><td>n</td><td>h</td><td>a</td><td>dysphagia, urinary dysf.</td><td>nd</td><td>Moderate (29)</td></tr><tr><td>2</td><td char="(" align="char">2(F)</td><td char="." align="char">3</td><td char="." align="char">42</td><td>3</td><td>+++</td><td char="." align="char">83.3</td><td>+++</td><td char="." align="char">37.5</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">21.5</td><td>n</td><td>h</td><td>a</td><td/><td>+, D</td><td>Severe (35)</td></tr><tr><td>3</td><td char="(" align="char">3(M)</td><td char="." align="char">8</td><td char="." align="char">45</td><td>3</td><td>+++</td><td char="." align="char">88.9</td><td>+++</td><td char="." align="char">33.3</td><td>&#8722;</td><td char="." align="char">10</td><td char="." align="char">21</td><td>a</td><td>n</td><td>a</td><td>Urinary dysf.</td><td>+, D</td><td>Severe (27)</td></tr><tr><td>4</td><td char="(" align="char">4(F)<sup>a</sup></td><td char="." align="char">3</td><td char="." align="char">33</td><td>3</td><td>+++</td><td char="." align="char">94.4</td><td>+++</td><td char="." align="char">33.3</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">23</td><td>n</td><td>n</td><td>a</td><td>Urinary dysf.</td><td>+</td><td>Severe (24)</td></tr><tr><td>5</td><td char="(" align="char">5(M)<sup>b</sup></td><td char="." align="char">5</td><td char="." align="char">32</td><td>2</td><td/><td char="." align="char"/><td/><td char="." align="char"/><td/><td char="." align="char"/><td char="." align="char"/><td>n</td><td>a</td><td>a</td><td/><td>nd</td><td/></tr><tr><td>6</td><td char="(" align="char">6(F)</td><td char="." align="char">1</td><td char="." align="char">39</td><td>3</td><td>+++</td><td char="." align="char">86.1</td><td>++</td><td char="." align="char">50.0</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">23.5</td><td>n</td><td>h</td><td>a</td><td>Urinary dysf.</td><td>+</td><td>Moderate (34)</td></tr><tr><td>7</td><td char="(" align="char">7(M)</td><td char="." align="char">1</td><td char="." align="char">33</td><td>3</td><td>+++</td><td char="." align="char">86.1</td><td>++</td><td char="." align="char">41.7</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">22.5</td><td>n</td><td>h</td><td>a</td><td/><td>nd</td><td>Moderate (24)</td></tr><tr><td char="." align="char"/><td char="(" align="char">8(F)</td><td char="." align="char">3</td><td char="." align="char">28</td><td>3</td><td/><td char="." align="char"/><td/><td char="." align="char"/><td/><td char="." align="char"/><td char="." align="char"/><td/><td>h</td><td>h</td><td/><td>nd</td><td>Moderate (23)</td></tr><tr><td>8</td><td char="(" align="char">9(M)</td><td char="." align="char">1</td><td char="." align="char">26</td><td>2</td><td>+++</td><td char="." align="char">66.7</td><td>+++</td><td char="." align="char">37.5</td><td>+</td><td char="." align="char">30</td><td char="." align="char">19.5</td><td>n</td><td>h</td><td>a</td><td>Cystic kidney right, dystonic posturing UL</td><td>+, D</td><td>Mild (17)</td></tr><tr><td>9</td><td char="(" align="char">10(F)</td><td char="." align="char">2</td><td char="." align="char">27</td><td>3</td><td>+++</td><td char="." align="char">100</td><td>+++</td><td char="." align="char">33.3</td><td>&#8722;</td><td char="." align="char">10</td><td char="." align="char">23</td><td>n</td><td>n</td><td>a</td><td>Urinary dysf.</td><td>+</td><td>Moderate (18)</td></tr><tr><td char="." align="char"/><td char="(" align="char">11(F)</td><td char="." align="char">1</td><td char="." align="char">25</td><td>3</td><td>+++</td><td char="." align="char">100</td><td>+++</td><td char="." align="char">41.7</td><td>&#8722;</td><td char="." align="char">40</td><td char="." align="char">27</td><td>h</td><td>h</td><td>a</td><td>Urinary dysf., dystonia UL</td><td>nd</td><td>nk</td></tr><tr><td char="." align="char"/><td char="(" align="char">12(M)</td><td char="." align="char">1</td><td char="." align="char">25</td><td>3</td><td>+++</td><td char="." align="char">63.9</td><td>++</td><td char="." align="char">41.7</td><td>+</td><td char="." align="char">30</td><td char="." align="char">19.5</td><td>n</td><td>n</td><td>a</td><td>Dystonia neck + UL, dysphagia</td><td>+</td><td>Mild (12)</td></tr><tr><td>10</td><td char="(" align="char">13(F)</td><td char="." align="char">2</td><td char="." align="char">29</td><td>2</td><td>+++</td><td char="." align="char">44.4</td><td>++</td><td char="." align="char">33.3</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">14</td><td>n</td><td>h</td><td>a</td><td>Urinary dysfunction</td><td>+</td><td>nk</td></tr><tr><td char="." align="char"/><td char="(" align="char">14(F)</td><td char="." align="char">3</td><td char="." align="char">31</td><td>2</td><td>++</td><td char="." align="char">38.9</td><td>+</td><td char="." align="char">45.8</td><td>&#8722;</td><td char="." align="char">40</td><td char="." align="char">16.5</td><td>a</td><td>a</td><td>a</td><td>Dysphagia</td><td>+, D</td><td>nk</td></tr><tr><td>11</td><td char="(" align="char">15(M)</td><td char="." align="char">12</td><td char="." align="char">39</td><td>3</td><td>na</td><td char="." align="char">100</td><td>+++</td><td char="." align="char">58.3</td><td>+</td><td char="." align="char">70</td><td char="." align="char">28</td><td>a</td><td>a</td><td>a</td><td>Dysphagia, urinary dysf.</td><td>nd</td><td>Severe (30)</td></tr><tr><td char="." align="char"/><td char="(" align="char">16(M)</td><td char="." align="char">6</td><td char="." align="char">41</td><td>2</td><td>++</td><td char="." align="char">61.1</td><td>++</td><td char="." align="char">37.5</td><td>&#8722;</td><td char="." align="char">10</td><td char="." align="char">16.5</td><td>a</td><td>n</td><td>a</td><td>impairment, diabetes, dysphagia</td><td>nd</td><td>Severe (38)</td></tr><tr><td>12</td><td char="(" align="char">17(F)</td><td char="." align="char"/><td char="." align="char"/><td/><td/><td char="." align="char"/><td/><td char="." align="char"/><td/><td char="." align="char"/><td char="." align="char"/><td/><td/><td/><td/><td/><td/></tr><tr><td char="." align="char"/><td char="(" align="char">18(F)</td><td char="." align="char"/><td char="." align="char"/><td/><td/><td char="." align="char"/><td/><td char="." align="char"/><td/><td char="." align="char"/><td char="." align="char"/><td/><td/><td/><td/><td/><td/></tr><tr><td>13</td><td char="(" align="char">19(M)<sup>a</sup></td><td char="." align="char">2</td><td char="." align="char">56</td><td>3</td><td>na</td><td char="." align="char">100</td><td>++</td><td char="." align="char">54.2</td><td>+</td><td char="." align="char">70</td><td char="." align="char">31.5</td><td>a</td><td>a</td><td>a</td><td>dysphagia, urinary dysf.</td><td>+,D</td><td>Severe (38)</td></tr><tr><td char="." align="char"/><td char="(" align="char">20(M)</td><td char="." align="char">1</td><td char="." align="char">56</td><td>3</td><td>na</td><td char="." align="char">100</td><td>na</td><td char="." align="char">54.2</td><td>na</td><td char="." align="char">60</td><td char="." align="char">30.5</td><td>a</td><td>a</td><td>a</td><td>Dysphagia, urinary dysf. cognitive impairment</td><td>+, D</td><td>Severe (48)</td></tr><tr><td>14</td><td char="(" align="char">21(M)</td><td char="." align="char">&lt;10</td><td char="." align="char">26</td><td/><td>+</td><td char="." align="char"/><td/><td char="." align="char"/><td>&#8722;</td><td char="." align="char"/><td char="." align="char"/><td/><td/><td/><td>Steatosis hepatis</td><td/><td/></tr><tr><td>15</td><td char="(" align="char">22(F)</td><td char="." align="char">3</td><td char="." align="char">53</td><td>3</td><td>+</td><td char="." align="char"/><td>+</td><td char="." align="char"/><td>&#8722;</td><td char="." align="char"/><td char="." align="char"/><td>l</td><td>n</td><td>a</td><td>Urinary dysfunction</td><td>+, D</td><td>Severe (53)</td></tr><tr><td>16</td><td char="(" align="char">23(M)<sup>b</sup></td><td char="." align="char">9</td><td char="." align="char">40</td><td>nk</td><td>+</td><td/><td>+</td><td char="." align="char"/><td>Nk</td><td char="." align="char"/><td char="." align="char"/><td>nk</td><td>b</td><td>a</td><td>nk</td><td>+</td><td>nk</td></tr></tbody></table>
###xml 4246 4247 4246 4247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 4256 4257 4256 4257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h</italic>
###xml 4273 4274 4273 4274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 4294 4296 4294 4296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nk</italic>
###xml 4308 4309 4308 4309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 4335 4337 4335 4337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nd</italic>
###xml 4348 4350 4348 4350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">na</italic>
###xml 4213 4369 4213 4369 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="15">+ mild, ++ moderate, +++ severe, <italic>n</italic> normal, <italic>h</italic> hyperreflexia, <italic>a</italic> areflexia, &#8722; none, <italic>nk</italic> not known, <italic>D</italic> secondary demyelinating, <italic>nd</italic> not done, <italic>na</italic> not able to assess</p>
###xml 4369 4370 4369 4370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 4385 4386 4385 4386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 4369 4404 4369 4404 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="16"><sup>a</sup>baclofen pump, <sup>b</sup>Non-Dutch patients</p>
###xml 4213 4404 4213 4404 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="15">+ mild, ++ moderate, +++ severe, <italic>n</italic> normal, <italic>h</italic> hyperreflexia, <italic>a</italic> areflexia, &#8722; none, <italic>nk</italic> not known, <italic>D</italic> secondary demyelinating, <italic>nd</italic> not done, <italic>na</italic> not able to assess</p><p textid="16"><sup>a</sup>baclofen pump, <sup>b</sup>Non-Dutch patients</p></table-wrap-foot>
###xml 2597 4404 2597 4404 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="14">Phenotypic characteristics of patients with ARSACS</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Family</th><th rowspan="2">Patient (M/F)</th><th rowspan="2">Age at onset (years)</th><th rowspan="2">Disease duration (years)</th><th rowspan="2">Disease stage<sup>31</sup></th><th rowspan="2">Gait spasticity</th><th rowspan="2">Lower body ataxia score (%)</th><th rowspan="2">Lower limb spasticity</th><th rowspan="2">Upper body ataxia score (%)</th><th rowspan="2">Upper limb spasticity</th><th rowspan="2">Remaining ataxia score (%)</th><th rowspan="2">SARA total score (0&#8211;40)</th><th colspan="3">Tendon reflexes</th><th rowspan="2">Additional symptoms</th><th rowspan="2">Sensomotor axonal neuropathy (EMG)</th><th rowspan="2">Cerebellar vermis atrophy MRI/CT (disease duration in years)</th></tr><tr><th>UL</th><th>Knee</th><th>Ankle</th></tr></thead><tbody><tr><td>1</td><td char="(" align="char">1(M)</td><td char="." align="char">3</td><td char="." align="char">36</td><td>2</td><td>+++</td><td char="." align="char">61.1</td><td>+++</td><td char="." align="char">25.0</td><td>&#8722;</td><td char="." align="char">30</td><td char="." align="char">17</td><td>n</td><td>h</td><td>a</td><td>dysphagia, urinary dysf.</td><td>nd</td><td>Moderate (29)</td></tr><tr><td>2</td><td char="(" align="char">2(F)</td><td char="." align="char">3</td><td char="." align="char">42</td><td>3</td><td>+++</td><td char="." align="char">83.3</td><td>+++</td><td char="." align="char">37.5</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">21.5</td><td>n</td><td>h</td><td>a</td><td/><td>+, D</td><td>Severe (35)</td></tr><tr><td>3</td><td char="(" align="char">3(M)</td><td char="." align="char">8</td><td char="." align="char">45</td><td>3</td><td>+++</td><td char="." align="char">88.9</td><td>+++</td><td char="." align="char">33.3</td><td>&#8722;</td><td char="." align="char">10</td><td char="." align="char">21</td><td>a</td><td>n</td><td>a</td><td>Urinary dysf.</td><td>+, D</td><td>Severe (27)</td></tr><tr><td>4</td><td char="(" align="char">4(F)<sup>a</sup></td><td char="." align="char">3</td><td char="." align="char">33</td><td>3</td><td>+++</td><td char="." align="char">94.4</td><td>+++</td><td char="." align="char">33.3</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">23</td><td>n</td><td>n</td><td>a</td><td>Urinary dysf.</td><td>+</td><td>Severe (24)</td></tr><tr><td>5</td><td char="(" align="char">5(M)<sup>b</sup></td><td char="." align="char">5</td><td char="." align="char">32</td><td>2</td><td/><td char="." align="char"/><td/><td char="." align="char"/><td/><td char="." align="char"/><td char="." align="char"/><td>n</td><td>a</td><td>a</td><td/><td>nd</td><td/></tr><tr><td>6</td><td char="(" align="char">6(F)</td><td char="." align="char">1</td><td char="." align="char">39</td><td>3</td><td>+++</td><td char="." align="char">86.1</td><td>++</td><td char="." align="char">50.0</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">23.5</td><td>n</td><td>h</td><td>a</td><td>Urinary dysf.</td><td>+</td><td>Moderate (34)</td></tr><tr><td>7</td><td char="(" align="char">7(M)</td><td char="." align="char">1</td><td char="." align="char">33</td><td>3</td><td>+++</td><td char="." align="char">86.1</td><td>++</td><td char="." align="char">41.7</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">22.5</td><td>n</td><td>h</td><td>a</td><td/><td>nd</td><td>Moderate (24)</td></tr><tr><td char="." align="char"/><td char="(" align="char">8(F)</td><td char="." align="char">3</td><td char="." align="char">28</td><td>3</td><td/><td char="." align="char"/><td/><td char="." align="char"/><td/><td char="." align="char"/><td char="." align="char"/><td/><td>h</td><td>h</td><td/><td>nd</td><td>Moderate (23)</td></tr><tr><td>8</td><td char="(" align="char">9(M)</td><td char="." align="char">1</td><td char="." align="char">26</td><td>2</td><td>+++</td><td char="." align="char">66.7</td><td>+++</td><td char="." align="char">37.5</td><td>+</td><td char="." align="char">30</td><td char="." align="char">19.5</td><td>n</td><td>h</td><td>a</td><td>Cystic kidney right, dystonic posturing UL</td><td>+, D</td><td>Mild (17)</td></tr><tr><td>9</td><td char="(" align="char">10(F)</td><td char="." align="char">2</td><td char="." align="char">27</td><td>3</td><td>+++</td><td char="." align="char">100</td><td>+++</td><td char="." align="char">33.3</td><td>&#8722;</td><td char="." align="char">10</td><td char="." align="char">23</td><td>n</td><td>n</td><td>a</td><td>Urinary dysf.</td><td>+</td><td>Moderate (18)</td></tr><tr><td char="." align="char"/><td char="(" align="char">11(F)</td><td char="." align="char">1</td><td char="." align="char">25</td><td>3</td><td>+++</td><td char="." align="char">100</td><td>+++</td><td char="." align="char">41.7</td><td>&#8722;</td><td char="." align="char">40</td><td char="." align="char">27</td><td>h</td><td>h</td><td>a</td><td>Urinary dysf., dystonia UL</td><td>nd</td><td>nk</td></tr><tr><td char="." align="char"/><td char="(" align="char">12(M)</td><td char="." align="char">1</td><td char="." align="char">25</td><td>3</td><td>+++</td><td char="." align="char">63.9</td><td>++</td><td char="." align="char">41.7</td><td>+</td><td char="." align="char">30</td><td char="." align="char">19.5</td><td>n</td><td>n</td><td>a</td><td>Dystonia neck + UL, dysphagia</td><td>+</td><td>Mild (12)</td></tr><tr><td>10</td><td char="(" align="char">13(F)</td><td char="." align="char">2</td><td char="." align="char">29</td><td>2</td><td>+++</td><td char="." align="char">44.4</td><td>++</td><td char="." align="char">33.3</td><td>&#8722;</td><td char="." align="char">20</td><td char="." align="char">14</td><td>n</td><td>h</td><td>a</td><td>Urinary dysfunction</td><td>+</td><td>nk</td></tr><tr><td char="." align="char"/><td char="(" align="char">14(F)</td><td char="." align="char">3</td><td char="." align="char">31</td><td>2</td><td>++</td><td char="." align="char">38.9</td><td>+</td><td char="." align="char">45.8</td><td>&#8722;</td><td char="." align="char">40</td><td char="." align="char">16.5</td><td>a</td><td>a</td><td>a</td><td>Dysphagia</td><td>+, D</td><td>nk</td></tr><tr><td>11</td><td char="(" align="char">15(M)</td><td char="." align="char">12</td><td char="." align="char">39</td><td>3</td><td>na</td><td char="." align="char">100</td><td>+++</td><td char="." align="char">58.3</td><td>+</td><td char="." align="char">70</td><td char="." align="char">28</td><td>a</td><td>a</td><td>a</td><td>Dysphagia, urinary dysf.</td><td>nd</td><td>Severe (30)</td></tr><tr><td char="." align="char"/><td char="(" align="char">16(M)</td><td char="." align="char">6</td><td char="." align="char">41</td><td>2</td><td>++</td><td char="." align="char">61.1</td><td>++</td><td char="." align="char">37.5</td><td>&#8722;</td><td char="." align="char">10</td><td char="." align="char">16.5</td><td>a</td><td>n</td><td>a</td><td>impairment, diabetes, dysphagia</td><td>nd</td><td>Severe (38)</td></tr><tr><td>12</td><td char="(" align="char">17(F)</td><td char="." align="char"/><td char="." align="char"/><td/><td/><td char="." align="char"/><td/><td char="." align="char"/><td/><td char="." align="char"/><td char="." align="char"/><td/><td/><td/><td/><td/><td/></tr><tr><td char="." align="char"/><td char="(" align="char">18(F)</td><td char="." align="char"/><td char="." align="char"/><td/><td/><td char="." align="char"/><td/><td char="." align="char"/><td/><td char="." align="char"/><td char="." align="char"/><td/><td/><td/><td/><td/><td/></tr><tr><td>13</td><td char="(" align="char">19(M)<sup>a</sup></td><td char="." align="char">2</td><td char="." align="char">56</td><td>3</td><td>na</td><td char="." align="char">100</td><td>++</td><td char="." align="char">54.2</td><td>+</td><td char="." align="char">70</td><td char="." align="char">31.5</td><td>a</td><td>a</td><td>a</td><td>dysphagia, urinary dysf.</td><td>+,D</td><td>Severe (38)</td></tr><tr><td char="." align="char"/><td char="(" align="char">20(M)</td><td char="." align="char">1</td><td char="." align="char">56</td><td>3</td><td>na</td><td char="." align="char">100</td><td>na</td><td char="." align="char">54.2</td><td>na</td><td char="." align="char">60</td><td char="." align="char">30.5</td><td>a</td><td>a</td><td>a</td><td>Dysphagia, urinary dysf. cognitive impairment</td><td>+, D</td><td>Severe (48)</td></tr><tr><td>14</td><td char="(" align="char">21(M)</td><td char="." align="char">&lt;10</td><td char="." align="char">26</td><td/><td>+</td><td char="." align="char"/><td/><td char="." align="char"/><td>&#8722;</td><td char="." align="char"/><td char="." align="char"/><td/><td/><td/><td>Steatosis hepatis</td><td/><td/></tr><tr><td>15</td><td char="(" align="char">22(F)</td><td char="." align="char">3</td><td char="." align="char">53</td><td>3</td><td>+</td><td char="." align="char"/><td>+</td><td char="." align="char"/><td>&#8722;</td><td char="." align="char"/><td char="." align="char"/><td>l</td><td>n</td><td>a</td><td>Urinary dysfunction</td><td>+, D</td><td>Severe (53)</td></tr><tr><td>16</td><td char="(" align="char">23(M)<sup>b</sup></td><td char="." align="char">9</td><td char="." align="char">40</td><td>nk</td><td>+</td><td/><td>+</td><td char="." align="char"/><td>Nk</td><td char="." align="char"/><td char="." align="char"/><td>nk</td><td>b</td><td>a</td><td>nk</td><td>+</td><td>nk</td></tr></tbody></table><table-wrap-foot><p textid="15">+ mild, ++ moderate, +++ severe, <italic>n</italic> normal, <italic>h</italic> hyperreflexia, <italic>a</italic> areflexia, &#8722; none, <italic>nk</italic> not known, <italic>D</italic> secondary demyelinating, <italic>nd</italic> not done, <italic>na</italic> not able to assess</p><p textid="16"><sup>a</sup>baclofen pump, <sup>b</sup>Non-Dutch patients</p></table-wrap-foot></table-wrap>
###xml 138 146 <span type="species:ncbi:9606">patients</span>
###xml 1233 1241 <span type="species:ncbi:9606">patients</span>
###xml 2634 2642 <span type="species:ncbi:9606">patients</span>
###xml 4396 4404 <span type="species:ncbi:9606">patients</span>
A systemic and comprehensive clinical examination by a neurologist, a cardiologist, and an ophthalmologist was performed in 16 identified patients, with mutations in the SACS gene, of families 1 through 4, 6, 7, 8 through 11, and 13 (Tables 1 and 2) after having obtained informed written consent. For our clinical assessments, we used the Scale for the Assessment and Rating of Ataxia (SARA), an eight-item scale that provides a comprehensive rating of simple ataxia tests: (item 1) gait, (item 2) stance, (item 3) sitting, (item 4) speech disturbance, (item 5) finger chase, (item 6) nose-finger test, (item 7) fast alternating hand movements, and (item 8) heel-shin slide [21]. We generated three composite subscores by taking the average scores of the subsets of SARA items. Averaging the scores of SARA items 1, 2, and 8 generated a lower body ataxia composite subscore that ranges from 0 (no ataxia) to 6 (most severe ataxia). An upper body composite subscore consisted of items 5, 6, and 7. The maximum scores on composite subscores may range from 0 (no ataxia) to 4 (severe ataxia). A "remaining" ataxia composite subscore consisted of items 3 and 4 that range from 0 (no ataxia) to 5 (worst). Finally, to fully characterize patients and compare the three composites, we normalized these subscores to percentages of the maximum score. Lower body spasticity was separately and semi-quantitatively rated according to the INAS (Inventory of Non-Ataxia Symptoms) as, none, mild, moderate, or severe [21]. Furthermore, the ataxia disease stages were defined as: 0 = normal; 1 = ataxia, but walking independently; 2 = permanently dependent on walking aids; 3 = permanently dependent on wheelchair; and 4 = death [22]. If possible, clinical records of previous neurological consultations were reviewed to obtain data on the disease progression. Table 1Homozygous or compound heterozygous mutations in SACS geneFamilyConsanguinityMutationsType of mutation1Yesp.Gln4054X/p.Gln4054XNonsense2Yesp.Arg728X/p.Arg728XNonsense3Nop.Lys1715X/p.Arg4331GlnNonsense/Missense4Nop.Gln4054X/p.Arg2002fsNonsense/Frameshift5aYesp.Glu1653X/p.Glu1653XNonsense6Nop.Gln4054X/c.2094-2 A>GNonsense/Splice-site7Yesp.Asp168Tyr/p.Asp168TyrMissense8Nop.Gln4054X/p.Gln4054XNonsense9Yesp.2801delGln/p.2801delGlnIn frame deletion10Not knownp.Gln4054X/p.Gln4054XNonsense11Noc.1891+1 del G/c.1891+1 del GSplice-site12Not knownp.Gln1709X/p.Gln4054XNonsense13Nop. Arg321X/p. Arg3636XNonsense14Nop.Gln4054X/p.Gln4054XNonsense15Nop.Arg321X/p.Trp492XNonsense/Nonsense16aNop.Leu3304fs/p.Leu3481ProFrameshift/MissenseaNon-Dutch patientsTable 2Phenotypic characteristics of patients with ARSACSFamilyPatient (M/F)Age at onset (years)Disease duration (years)Disease stage31Gait spasticityLower body ataxia score (%)Lower limb spasticityUpper body ataxia score (%)Upper limb spasticityRemaining ataxia score (%)SARA total score (0-40)Tendon reflexesAdditional symptomsSensomotor axonal neuropathy (EMG)Cerebellar vermis atrophy MRI/CT (disease duration in years)ULKneeAnkle11(M)3362+++61.1+++25.0-3017nhadysphagia, urinary dysf.ndModerate (29)22(F)3423+++83.3+++37.5-2021.5nha+, DSevere (35)33(M)8453+++88.9+++33.3-1021anaUrinary dysf.+, DSevere (27)44(F)a3333+++94.4+++33.3-2023nnaUrinary dysf.+Severe (24)55(M)b5322naand66(F)1393+++86.1++50.0-2023.5nhaUrinary dysf.+Moderate (34)77(M)1333+++86.1++41.7-2022.5nhandModerate (24)8(F)3283hhndModerate (23)89(M)1262+++66.7+++37.5+3019.5nhaCystic kidney right, dystonic posturing UL+, DMild (17)910(F)2273+++100+++33.3-1023nnaUrinary dysf.+Moderate (18)11(F)1253+++100+++41.7-4027hhaUrinary dysf., dystonia ULndnk12(M)1253+++63.9++41.7+3019.5nnaDystonia neck + UL, dysphagia+Mild (12)1013(F)2292+++44.4++33.3-2014nhaUrinary dysfunction+nk14(F)3312++38.9+45.8-4016.5aaaDysphagia+, Dnk1115(M)12393na100+++58.3+7028aaaDysphagia, urinary dysf.ndSevere (30)16(M)6412++61.1++37.5-1016.5anaimpairment, diabetes, dysphagiandSevere (38)1217(F)18(F)1319(M)a2563na100++54.2+7031.5aaadysphagia, urinary dysf.+,DSevere (38)20(M)1563na100na54.2na6030.5aaaDysphagia, urinary dysf. cognitive impairment+, DSevere (48)1421(M)<1026+-Steatosis hepatis1522(F)3533++-lnaUrinary dysfunction+, DSevere (53)1623(M)b940nk++Nknkbank+nk+ mild, ++ moderate, +++ severe, n normal, h hyperreflexia, a areflexia, - none, nk not known, D secondary demyelinating, nd not done, na not able to assessabaclofen pump, bNon-Dutch patients
###end p 11
###begin p 12
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
Homozygous or compound heterozygous mutations in SACS gene
###end p 12
###begin p 13
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 11 19 <span type="species:ncbi:9606">patients</span>
aNon-Dutch patients
###end p 13
###begin p 14
###xml 30 38 <span type="species:ncbi:9606">patients</span>
Phenotypic characteristics of patients with ARSACS
###end p 14
###begin p 15
###xml 33 34 33 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 43 44 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h</italic>
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 81 83 81 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nk</italic>
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 122 124 122 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nd</italic>
###xml 135 137 135 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">na</italic>
+ mild, ++ moderate, +++ severe, n normal, h hyperreflexia, a areflexia, - none, nk not known, D secondary demyelinating, nd not done, na not able to assess
###end p 15
###begin p 16
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 27 35 <span type="species:ncbi:9606">patients</span>
abaclofen pump, bNon-Dutch patients
###end p 16
###begin title 17
Results
###end title 17
###begin title 18
Mutation analysis
###end title 18
###begin p 19
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 543 544 543 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 631 632 631 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 3054 3060 3054 3060 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 3110 3111 3110 3111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 3122 3123 3122 3123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 3123 3124 3123 3124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 3123 3124 3123 3124 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a</italic></sup>
###xml 3134 3135 3134 3135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 3146 3151 3146 3147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;</italic>
###xml 3162 3163 3158 3159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 3176 3178 3172 3174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ss</italic>
###xml 3060 3190 3060 3186 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="20">Overview of different mutations in the SACS gene. <italic>M</italic> missense, <italic>N</italic><sup><italic>a</italic></sup> founder, <italic>N</italic> nonsense, <italic>&#916;</italic> deletion, <italic>F</italic> frameshift, <italic>Ss</italic> splice site</p>
###xml 3060 3190 3060 3186 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="20">Overview of different mutations in the SACS gene. <italic>M</italic> missense, <italic>N</italic><sup><italic>a</italic></sup> founder, <italic>N</italic> nonsense, <italic>&#916;</italic> deletion, <italic>F</italic> frameshift, <italic>Ss</italic> splice site</p></caption>
###xml 3190 3190 3186 3186 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10048_2008_131_Fig1_HTML" id="MO1"/>
###xml 3054 3190 3054 3186 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="20">Overview of different mutations in the SACS gene. <italic>M</italic> missense, <italic>N</italic><sup><italic>a</italic></sup> founder, <italic>N</italic> nonsense, <italic>&#916;</italic> deletion, <italic>F</italic> frameshift, <italic>Ss</italic> splice site</p></caption><graphic position="anchor" xlink:href="10048_2008_131_Fig1_HTML" id="MO1"/></fig>
###xml 22 30 <span type="species:ncbi:9606">patients</span>
###xml 213 221 <span type="species:ncbi:9606">patients</span>
###xml 270 278 <span type="species:ncbi:9606">patients</span>
###xml 321 329 <span type="species:ncbi:9606">patients</span>
###xml 1175 1183 <span type="species:ncbi:9606">patients</span>
###xml 3008 3016 <span type="species:ncbi:9606">patients</span>
In 16 out of 43 index patients, mutations in the SACS gene were identified. In six families, the mutations could be confirmed in seven additional affected siblings or relatives. We thus identified mutations in 23 patients. Molecular genetic analysis revealed nine index patients with homozygous mutations and seven index patients with compound heterozygous mutations (Table 1). In total, 16 different novel mutations were identified: eight nonsense, three missense, two splice-site, one in frame deletion, and two frame-shift mutations (Table 1). The mutations occurred throughout the whole gene without any hot-spot regions (Fig. 1). All mutations most likely lead to a loss of function. For the in frame deletion (p.2801delGln) in family 9, the prediction programs are inconclusive. Whether this mutation indeed leads to a loss of function is unknown. However, the p.2801delGln mutation segregated with the disease in the family was not identified in 100 control alleles, and the mutation is located in a conserved region of the gene. In general, a 3-bp deletion is considered to have a larger deleterious effect on the protein function than a missense mutation. All three patients carrying the p.2801delGln display a relatively severe phenotype, as all were wheelchair-bound before the age of 15. In family 3, the identified heterozygous missense mutation (p.Arg4331Gln) is located in the highly conserved DnaJ domain in exon 6 of the SACS gene. This mutation is predicted to be intolerant (PolyPhen--and SIFT-) and probably leads to loss of function of the protein. The mutation (c. 2094-2 A>G) in family 6 presumably induces skipping of exon 5 due to loss of the splice-acceptor site (, , ). Skipping of exon 5 most likely leads to absence of sacsin protein. The transcript lacking exon 5 is likely subject to nonsense-mediated messenger RNA decay (NMD) due to a downstream protein truncating codon (PTC) occurring as a result of a shift of the reading frame. The splice site mutation (c.1891+1 del G) in family 11 affects the splice-donor site, either leading to a downstream PTC and subsequent NMD or to skipping of exon 5. The identified homozygous missense mutation (p.Asp168Tyr) in family 7 is considered to be pathogenic because the amino acid chance is predicted to be intolerant (PolyPhen and SIFT), the change is located in a conserved region, and was not identified in 100 control alleles. The same mutation was also identified in another affected relative of whom both parents were also consanguineous within the same extended family. The mutation most likely leads to a conformation change of the protein resulting in dysfunction of the protein. The missense mutation identified in family 16 (English descent) is most likely pathogenic because it concerns a drastic change of an evolutionary highly conserved amino acid; however, we are still waiting for DNA to confirm the mutation in the affected sibling. The nonsense mutation p.Gln3907X, identified in 7 out of 14 unrelated Dutch ARSACS patients is a common Dutch nonsense mutation. Fig. 1Overview of different mutations in the SACS gene. M missense, Na founder, N nonsense, Delta deletion, F frameshift, Ss splice site
###end p 19
###begin p 20
###xml 50 51 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 62 63 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 63 64 63 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a</italic></sup>
###xml 74 75 74 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 86 91 86 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;</italic>
###xml 102 103 98 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 116 118 112 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ss</italic>
Overview of different mutations in the SACS gene. M missense, Na founder, N nonsense, Delta deletion, F frameshift, Ss splice site
###end p 20
###begin title 21
Clinical data
###end title 21
###begin p 22
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 517 521 517 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 811 812 811 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 11 19 <span type="species:ncbi:9606">patients</span>
###xml 163 169 <span type="species:ncbi:9103">Turkey</span>
###xml 213 221 <span type="species:ncbi:9606">patients</span>
###xml 285 293 <span type="species:ncbi:9606">patients</span>
###xml 425 433 <span type="species:ncbi:9606">patients</span>
###xml 499 507 <span type="species:ncbi:9606">patients</span>
Twenty-one patients from 14 different families with homozygous or compound heterozygous mutations in the SACS gene were of Dutch descent. Family 5 originated from Turkey and family 16 is from English descent. All patients identified were adults, but onset of gait impairment in the 21 patients of whom clinical data were available was before age 13 (mean 3.7 years, SD 3.1, range 1-12). The mean disease duration in these 21 patients was 36.2 years (SD 9.9, range 25-56). Clinically, all identified patients carrying SACS mutations showed a remarkable uniform phenotype: mild to moderate ataxia of the upper half of the body with a severe spastic paresis, with sensory and motor neuropathy of the lower limbs and very mild motor neuropathy of the upper limbs, and with cerebellar atrophy on neuroimaging (Table 2). This phenotype is consistent with the core ARSACS phenotype previously described.
###end p 22
###begin p 23
###xml 55 56 55 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2320 2321 2320 2321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 2573 2579 2573 2579 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 2579 2789 2579 2789 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="24">Red-free fundus photograph of patient no. 12; increased demarcation of the retinal nerve fibers, partially embedded retinal vessels; and a distinct tortuosity of the retinal vessels near the optic disc are seen</p>
###xml 2579 2789 2579 2789 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="24">Red-free fundus photograph of patient no. 12; increased demarcation of the retinal nerve fibers, partially embedded retinal vessels; and a distinct tortuosity of the retinal vessels near the optic disc are seen</p></caption>
###xml 2789 2789 2789 2789 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10048_2008_131_Fig2_HTML" id="MO2"/>
###xml 2573 2789 2573 2789 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="24">Red-free fundus photograph of patient no. 12; increased demarcation of the retinal nerve fibers, partially embedded retinal vessels; and a distinct tortuosity of the retinal vessels near the optic disc are seen</p></caption><graphic position="anchor" xlink:href="10048_2008_131_Fig2_HTML" id="MO2"/></fig>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
###xml 868 876 <span type="species:ncbi:9606">patients</span>
###xml 1020 1028 <span type="species:ncbi:9606">patients</span>
###xml 1077 1085 <span type="species:ncbi:9606">patients</span>
###xml 1242 1249 <span type="species:ncbi:9606">patient</span>
###xml 1311 1319 <span type="species:ncbi:9606">patients</span>
###xml 1520 1527 <span type="species:ncbi:9606">patient</span>
###xml 1570 1578 <span type="species:ncbi:9606">patients</span>
###xml 1803 1811 <span type="species:ncbi:9606">patients</span>
###xml 1889 1896 <span type="species:ncbi:9606">patient</span>
###xml 2000 2007 <span type="species:ncbi:9606">patient</span>
###xml 2046 2054 <span type="species:ncbi:9606">patients</span>
###xml 2190 2198 <span type="species:ncbi:9606">patients</span>
###xml 2331 2338 <span type="species:ncbi:9606">patient</span>
###xml 2385 2393 <span type="species:ncbi:9606">patients</span>
###xml 2534 2541 <span type="species:ncbi:9606">patient</span>
###xml 2609 2616 <span type="species:ncbi:9606">patient</span>
At the time of the clinical examination, the majority (n = 13) of the patients were permanently wheelchair-dependent. The current clinical details in combination with older medical records suggest that the initial years of disease were dominated by a slowly progressive cerebellar ataxia with subsequent lower limb spasticity, followed by features of peripheral neuropathy. This ultimately led to an impressive and severe lower limb and gait impairment, while oculomotor disturbances, dysarthria, and upper limb ataxia appeared to progress much slower. The sensorimotor peripheral neuropathy was evident from distal muscle atrophy and weakness, foot deformities, impaired tactile and vibration sense, and eventually a decrease or loss of tendon reflexes in the legs. Slight dysphagia and urinary dysfunction (predominantly urge incontinence) were fairly common. Three patients (no. 9, no. 11, and no. 12) displayed subtle yet unequivocal abnormal posturing of the hands and/or neck, indicative of mild dystonia in these patients; other extrapyramidal features were absent. Two patients (no. 4 and no. 20) used an intrathecal Baclofen pump, which influences the outcome of the SARA score on lower limb function. In our Dutch ARSACS cohort, no patient was mentally retarded nor showed signs of dementia. Only two patients displayed mild cognitive problems. One of these (no. 15), had suffered from meningitis at age 44 and developed diabetes at age 56. He had experienced a recent episode of epileptic seizures. The other patient (no. 20) had suffered from strokes. In 15 patients who had undergone a brain magnetic resonance imaging (MRI) or computed tomography (CT) scan, moderate to severe mid-cerebellar (vermis) atrophy was noticed, the severity of which appeared to parallel disease duration. In 12 patients, an electrocardiogram (ECG) was made and echocardiography was performed. One patient (no. 1) showed a right bundle branch block on ECG; no other ECG abnormalities were seen either in this patient or in any other. None of the examined patients displayed signs of mitral valve prolapse or any other cardiac abnormalities on echocardiography. On ophthalmologic examination, all 14 patients that were examined showed demarcation of the retinal nerve fibers that embedded parts of the vessels near the disc (Fig. 2). In one patient (no. 7), a papilla leparina could be seen. In patients no. 19 and no. 20, no ophthalmologic examination and cardiologic examination was done, and no cardiologic examination could be performed in patient no. 6 due to limited mobility. Fig. 2Red-free fundus photograph of patient no. 12; increased demarcation of the retinal nerve fibers, partially embedded retinal vessels; and a distinct tortuosity of the retinal vessels near the optic disc are seen
###end p 23
###begin p 24
###xml 30 37 <span type="species:ncbi:9606">patient</span>
Red-free fundus photograph of patient no. 12; increased demarcation of the retinal nerve fibers, partially embedded retinal vessels; and a distinct tortuosity of the retinal vessels near the optic disc are seen
###end p 24
###begin title 25
Discussion
###end title 25
###begin p 26
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 205 209 205 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 114 122 <span type="species:ncbi:9606">patients</span>
In this report, we demonstrate that in the Dutch population, mutations in the SACS gene are quite prevalent among patients with early-onset cerebellar ataxia. Moreover, those who harbored mutations in the SACS gene showed a strikingly uniform and recognizable clinical phenotype consisting of cerebellar ataxia with onset before the age of 13, lower limb spasticity and sensorimotor axonal neuropathy, and cerebellar (vermis) atrophy on neuroimaging.
###end p 26
###begin p 27
###xml 438 442 438 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 785 789 785 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 1129 1131 1129 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 1132 1134 1132 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 457 465 <span type="species:ncbi:9606">patients</span>
###xml 583 591 <span type="species:ncbi:9606">patients</span>
###xml 707 715 <span type="species:ncbi:9606">patients</span>
###xml 995 1003 <span type="species:ncbi:9606">patients</span>
###xml 1069 1077 <span type="species:ncbi:9606">patients</span>
Originally believed to be a rare disease that was present in Quebec only, ARSACS turns out to constitute a fairly common phenotype in the diverse group of early-onset recessive cerebellar ataxias. We identified many different novel mutations throughout the whole gene. The clinical phenotype is specific and recognizable, thus offering a good indication for mutation analysis. In this study, the detection rate of ARSACS mutations in the SACS gene among 43 patients with an early-onset recessive cerebellar ataxia was 37%. Retrospectively, we can conclude that all identified ARSACS patients displayed mild to moderate upper body ataxia and severe spastic paresis of the lower limbs with neuropathy. In two patients with more or less similar neurological features, no mutations in the SACS gene could be identified. This might be due to genetic heterogeneity for the spastic ataxia phenotype. The principle of genetic heterogeneity for the spastic ataxia phenotype is demonstrated by reports of patients with spastic ataxia who harbor mutations in the FRDA gene and of patients who are linked to the SPG30, SAX2, and ARSAL loci [23-28].
###end p 27
###begin p 28
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SACS</italic>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 38 46 <span type="species:ncbi:9606">patients</span>
###xml 101 109 <span type="species:ncbi:9606">patients</span>
Furthermore, in retrospect, these two patients had less lower limb spasticity compared to the ARSACS patients and, contrary to these, prominent atrophy and weakness of the intrinsic hand muscles. On the other hand, we cannot exclude that mutations in both SACS alleles might have remained undetected, for instance when they reside in parts of the gene that have not been analyzed, e.g., regulatory regions upstream of the gene or deep in the introns. The average age of onset of the disease in our cohort is comparable to what has been described in literature, except for one Tunisian case in whom the age of onset was 20 years [29].
###end p 28
###begin p 29
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 623 624 623 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 626 627 626 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 629 630 629 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 632 634 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 862 863 862 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 76 84 <span type="species:ncbi:9606">patients</span>
###xml 178 186 <span type="species:ncbi:9606">patients</span>
###xml 277 285 <span type="species:ncbi:9606">patients</span>
###xml 555 563 <span type="species:ncbi:9606">patients</span>
###xml 613 621 <span type="species:ncbi:9606">patients</span>
###xml 665 673 <span type="species:ncbi:9606">patients</span>
Mitral valve prolapse has been mentioned as a frequent feature among ARSACS patients from Quebec [4]. After the publication of Bouchard et al. [4], cardiac involvement in ARSACS patients has not been further reported. This is consistent with the absence of cardiac symptoms in patients from our cohort. Therefore, we conclude that cardiac involvement is not a clinical characteristic of ARSACS. Increased demarcation of the retinal fibers embedding parts of the vessels near the disc has previously been reported as being a common feature of ARSACS among patients originating from Quebec and of some other ARSACS patients [4, 8, 9, 13, 15, 30, 31]. Eight of the 14 patients whom we ophthalmologically examined not only did show increased demarcation of the retinal nerve fibers but also had a distinct tortuosity of the retinal vessels near the optic disc (Fig. 2).
###end p 29
###begin p 30
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 654 656 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
###xml 902 903 902 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 905 907 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 139 147 <span type="species:ncbi:9606">patients</span>
###xml 361 369 <span type="species:ncbi:9606">patients</span>
###xml 456 464 <span type="species:ncbi:9606">patients</span>
###xml 692 700 <span type="species:ncbi:9606">patients</span>
###xml 1105 1113 <span type="species:ncbi:9606">patients</span>
Our data demonstrate that mental retardation, defined as having an IQ of less than 70, is not a feature of ARSACS. So far, only two ARSACS patients described in the literature fulfill this criterion. However, as their spastic-ataxic sibs were not mentally retarded, the retardation is most likely an independent feature not related to ARSACS [13, 17]. In three patients, mild dystonic features were observed. Dystonia has not been reported in other ARSACS patients, but extrapyrimadal features such as dystonia and chorea are known to occur in Friedreich's ataxia, ataxia telangiectasia, ataxia with oculomotor apraxia type 1, and ataxia with vitamin E [32-35]. So far, only two adult ARSACS patients (with mutations in the SACS gene) without lower limb spasticity have been reported. The absence of this feature was suggested to be due to the severe progressive neuropathy that could mask spasticity [9, 18]. Assuming a uniform clinical ARSACS phenotype and given the still labor-intensive procedure of fully sequencing this large gene, it seems currently advisable to screen the SACS gene only in those patients who present with early-onset slowly progressive cerebellar ataxia, with lower limb spasticity and peripheral neuropathy, with relatively mild oculomotor disturbances and upper limb ataxia, and in whom Friedreich's ataxia has been excluded.
###end p 30
###begin p 31
###xml 97 105 <span type="species:ncbi:9606">patients</span>
###xml 456 464 <span type="species:ncbi:9606">patients</span>
In conclusion, 16 novel SACS mutations were identified in 16 different families consisting of 23 patients in whom the clinical phenotype was very similar and consistent with the core ARSACS phenotype, mild to moderate upper body ataxia and severe spastic paresis of the lower limbs and neuropathy, with cerebellar atrophy revealed by neuroimaging. The identification of several different mutations in the SACS gene in this first mutational screen in Dutch patients with an early-onset cerebellar ataxia indicates that ARSACS is more prevalent in the Dutch population than previously assumed. This could also be the case in other populations.
###end p 31
###begin p 32
###xml 23 31 <span type="species:ncbi:9606">patients</span>
We are grateful to the patients for their participation, to the referring clinicians, and especially to Dr. A. Fryer, Dr. P.F. Ippel, Dr. A.T..J.M. Helderman-van den Enden, Dr. C.C. Verschuuren-Bemelmans, and Prof. Dr. M.S. van der Knaap for their clinical information.
###end p 32
###begin p 33
This work was supported by a grant from the Netherlands Organization of Health Research and Development (NK, ZonMW RM000085).
###end p 33
###begin p 34
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 34
###begin title 35
References
###end title 35
###begin article-title 36
Clinical features and molecular genetics of autosomal recessive cerebellar ataxias
###end article-title 36
###begin article-title 37
Diagnosis and management of early- and late-onset cerebellar ataxia
###end article-title 37
###begin article-title 38
Recent advances in hereditary spinocerebellar ataxias
###end article-title 38
###begin article-title 39
Autosomal recessive spastic ataxia of Charlevoix-Saguenay
###end article-title 39
###begin article-title 40
ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11.5-kb ORF
###end article-title 40
###begin article-title 41
Sacsin-related ataxia (ARSACS): expanding the genotype upstream from the gigantic exon
###end article-title 41
###begin article-title 42
Sacsin-related ataxia caused by the novel nonsense mutation Arg4325X
###end article-title 42
###begin article-title 43
Phenotypic features and genetic findings in sacsin-related autosomal recessive ataxia in Tunisia
###end article-title 43
###begin article-title 44
A phenotype without spasticity in sacsin-related ataxia
###end article-title 44
###begin article-title 45
Novel compound heterozygous mutations in sacsin-related ataxia
###end article-title 45
###begin article-title 46
Sacsin-related autosomal recessive ataxia without prominent retinal myelinated fibers in Japan
###end article-title 46
###begin article-title 47
###xml 38 43 <span type="species:ncbi:9606">woman</span>
A novel sacsin mutation in a Japanese woman showing clinical uniformity of autosomal recessive spastic ataxia of Charlevoix-Saguenay
###end article-title 47
###begin article-title 48
Identification of a SACS gene missense mutation in ARSACS
###end article-title 48
###begin article-title 49
Novel mutation of SACS gene in a Spanish family with autosomal recessive spastic ataxia
###end article-title 49
###begin article-title 50
###xml 107 113 <span type="species:ncbi:9103">Turkey</span>
Private SACS mutations in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) families from Turkey
###end article-title 50
###begin article-title 51
Novel SACS mutations in autosomal recessive spastic ataxia of Charlevoix-Saguenay type
###end article-title 51
###begin article-title 52
A novel mutation in SACS gene in a family from southern Italy
###end article-title 52
###begin article-title 53
An unusual case of a spasticity-lacking phenotype with a novel SACS mutation
###end article-title 53
###begin article-title 54
Novel SACS mutation in a Belgian family with sacsin-related ataxia
###end article-title 54
###begin article-title 55
New mutation in the non-gigantic exon of SACS in Japanese siblings
###end article-title 55
###begin article-title 56
Scale for the assessment and rating of ataxia: development of a new clinical scale
###end article-title 56
###begin article-title 57
###xml 73 81 <span type="species:ncbi:9606">patients</span>
The natural history of degenerative ataxia: a retrospective study in 466 patients
###end article-title 57
###begin article-title 58
Friedreich ataxia with minimal GAA expansion presenting as adult-onset spastic ataxia
###end article-title 58
###begin article-title 59
Friedreich's ataxia: treatment within reach
###end article-title 59
###begin article-title 60
Broadened Friedreich's ataxia phenotype after gene cloning. Minimal GAA expansion causes late-onset spastic ataxia
###end article-title 60
###begin article-title 61
Autosomal recessive spastic paraplegia (SPG30) with mild ataxia and sensory neuropathy maps to chromosome 2q37.3
###end article-title 61
###begin article-title 62
A novel locus for autosomal recessive spastic ataxia on chromosome 17p
###end article-title 62
###begin article-title 63
A new autosomal recessive spastic ataxia associated with frequent white matter changes maps to 2q33-34
###end article-title 63
###begin article-title 64
Linkage to chromosome 13q11-12 of an autosomal recessive cerebellar ataxia in a Tunisian family
###end article-title 64
###begin article-title 65
Autosomal recessive spastic ataxia of Charlevoix-Saguenay
###end article-title 65
###begin article-title 66
Autosomal recessive spastic ataxia of Charlevoix-Saguenay in two unrelated Turkish families
###end article-title 66
###begin article-title 67
Movement disorders in Friedreich's ataxia
###end article-title 67
###begin article-title 68
Ataxia telangiectasia in the British Isles: the clinical and laboratory features of 70 affected individuals
###end article-title 68
###begin article-title 69
###xml 106 114 <span type="species:ncbi:9606">patients</span>
Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients
###end article-title 69
###begin article-title 70
Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families
###end article-title 70

